<SEC-DOCUMENT>0001558370-22-017426.txt : 20221110
<SEC-HEADER>0001558370-22-017426.hdr.sgml : 20221110
<ACCEPTANCE-DATETIME>20221110161741
ACCESSION NUMBER:		0001558370-22-017426
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20221110
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221110
DATE AS OF CHANGE:		20221110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EVgo Inc.
		CENTRAL INDEX KEY:			0001821159
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-RETAIL STORES, NEC [5990]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39572
		FILM NUMBER:		221377480

	BUSINESS ADDRESS:	
		STREET 1:		11835 WEST OLYMPIC BOULEVARD
		STREET 2:		SUITE 900E
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90064
		BUSINESS PHONE:		(310) 954-2900

	MAIL ADDRESS:	
		STREET 1:		11835 WEST OLYMPIC BOULEVARD
		STREET 2:		SUITE 900E
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90064

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EVgo Inc
		DATE OF NAME CHANGE:	20210702

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Climate Change Crisis Real Impact I Acquisition Corp
		DATE OF NAME CHANGE:	20200814
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>evgo-20221110x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>

      <!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 10.1.0.3 -->
      <!-- Based on: iXBRL 1.1 -->
      <!-- Created on: 11/10/2022 9:06:55 PM -->
      <!-- iXBRL Library version: 1.0.8263.24741 -->
      <!-- iXBRL Service Job ID: 9d4facdf-8a17-4a9b-9a93-5612d623f9cc -->

  <html xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:evgo="http://www.deitaxonomy.com/20221110" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrldi="http://xbrl.org/2006/xbrldi"><head><meta content="text/html" http-equiv="content-type" /><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:EntityCentralIndexKey" id="Tc_VzNCGOKRwE-ygZSqe1pCHA_2_1">0001821159</ix:nonNumeric><ix:nonNumeric contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:AmendmentFlag" id="Tc_QqXl-2SUOkGwxPCP2xYIgw_3_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="evgo-20221110.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="Duration_11_10_2022_To_11_10_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_ev6bO2MilkqMaKdp7dSOtA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001821159</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-10</xbrli:startDate><xbrli:endDate>2022-11-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_10_2022_To_11_10_2022_us-gaap_StatementClassOfStockAxis_evgo_RedeemableWarrantsForClassCommonStockMember_iLzXOQ-tWEyaN1haO_HNkA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001821159</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">evgo:RedeemableWarrantsForClassCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-10</xbrli:startDate><xbrli:endDate>2022-11-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001821159</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-10</xbrli:startDate><xbrli:endDate>2022-11-10</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="padding-top:1.0px;border-top:3.0pt solid #000000;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-top:1pt;border-top:1.0pt solid #000000;margin:0pt;"><span style="margin-bottom:10pt;visibility:hidden;">&#8203;</span></p></div><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">UNITED STATES</b><b style="font-size:12pt;font-weight:bold;"><br /></b><b style="font-size:12pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b><b style="font-size:10pt;font-weight:bold;"><br /></b>Washington, D.C. 20549</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 180pt;"><span style="margin-bottom:5pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><a id="_Hlk76571095"></a><p style="font-family:'Times New Roman','Times','serif';font-size:20pt;font-weight:bold;text-align:center;margin:0pt;">FORM <ix:nonNumeric contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:DocumentType" id="Narr_EHx7cgsh90-FlcN0VPZjOQ">8-K</ix:nonNumeric><br /><span style="font-size:14pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 6pt 0pt;">CURRENT REPORT</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;">Pursuant to Section 13 or 15(d) of <br />the Securities Exchange Act of 1934</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;"><b style="font-size:8pt;font-weight:bold;">Date of Report (Date of earliest event reported): </b><ix:nonNumeric format="ixt:datemonthdayyearen" contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:DocumentPeriodEndDate" id="Narr_o7rTK0RyZEO8kRZeEgcvQg"><b style="font-size:8pt;font-weight:bold;">November 10, 2022</b></ix:nonNumeric><b style="font-size:8pt;font-weight:bold;"> </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12.5pt;text-align:center;margin:0pt 0pt 1pt 6pt;"><ix:nonNumeric contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:EntityRegistrantName" id="Narr_ugoQOZFHrkO2bb2rLRLKfQ"><b style="font-weight:bold;">EVgo Inc.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 1pt 6pt;">(Exact name of registrant as specified in its charter)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><a id="_dc09e012_efe2_4a5e_aeb0_a17dd4081a72"></a><a id="Tc_KXzWWwO3XUWPKSC68rNppA_2_0"></a><a id="Tc_rcslsvOXxkmO8Ogp3FNLSw_2_2"></a><a id="Tc_z48VeER1VE238N_U1lyetA_2_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.14957047%;padding-left:5.75pt;padding-right:5.75pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:31.55%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.66%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:31.56%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.66%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:31.56%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:31.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric format="ixt-sec:stateprovnameen" contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:EntityIncorporationStateCountryCode" id="Tc_KTkj-axMB0KgSjvk9xBgOQ_1_0"><b style="font-weight:bold;">Delaware</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.66%;border-bottom:1px solid transparent;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:31.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:EntityFileNumber" id="Tc_3KQeXlzP40Gj_bn9Qsv0qw_1_2"><b style="font-weight:bold;">001-39572</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.66%;border-bottom:1px solid transparent;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:31.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:EntityTaxIdentificationNumber" id="Tc_hFMTWYwLxki_woS8Sg7MvA_1_4"><b style="font-weight:bold;">85-2326098</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:31.55%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 1pt 0pt;">(State or other jurisdiction of<br />incorporation or organization)</p></td><td style="vertical-align:bottom;width:2.66%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 1pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:31.56%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 1pt 0pt;">(Commission File Number)</p></td><td style="vertical-align:bottom;width:2.66%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 1pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:31.56%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 1pt 0pt;">(I.R.S. Employer <br />Identification Number)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><a id="_73bbc072_7d80_4477_ba26_ceb5cab52d47"></a><a id="Tc_e86cLu0evkqZ4NFQzCZVXQ_1_0"></a><a id="Tc_iuFqs84oZ0md9tvJSL2eIg_2_0"></a><a id="Tc__7GwbKWXAUeWNlIZfHGJ-w_2_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:5.75pt;padding-right:5.75pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:47.79%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:4.4%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:47.79%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:EntityAddressAddressLine1" id="Narr_c2QX8VUWH06DHtz0p03ZUQ"><b style="font-size:9pt;font-weight:bold;">11835 West Olympic Boulevard</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:EntityAddressAddressLine2" id="Narr_L0tRL59vaUyu0h45cQJENQ"><b style="font-size:9pt;font-weight:bold;">Suite 900E</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;"><br /></b><ix:nonNumeric contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:EntityAddressCityOrTown" id="Narr_Brt6eEusP0qG1Ox3ubPChg"><b style="font-size:9pt;font-weight:bold;">Los Angeles</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">, </b><ix:nonNumeric format="ixt-sec:stateprovnameen" contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:EntityAddressStateOrProvince" id="Narr_BXNup94HCE6UYxoXJwYntg"><b style="font-size:9pt;font-weight:bold;">California</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:4.4%;border-bottom:1px solid transparent;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:47.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:EntityAddressPostalZipCode" id="Tc_1pNV0pFBpUup_gt05130OA_1_2"><b style="font-size:9pt;font-weight:bold;">90064</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:47.79%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 1pt 0pt;">(Address of principal executive offices)</p></td><td style="vertical-align:bottom;width:4.4%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 1pt 0pt;"><span style="font-size:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.79%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 1pt 0pt;">(Zip Code)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Registrant&#8217;s telephone number, including area code: <b style="font-weight:bold;">(</b><ix:nonNumeric contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:CityAreaCode" id="Narr_dx6xTN2Bikint62PHGMTSA"><b style="font-weight:bold;">877</b></ix:nonNumeric><b style="font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:LocalPhoneNumber" id="Narr_AfOY9U0qWUyUxprroZRwEw"><b style="font-weight:bold;">494-3833</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:6pt 0pt 6pt 0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:</p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:6pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:WrittenCommunications" id="Narr_ZUsE1nGBYkuraBafWENOhQ"><span style="font-family:'Segoe UI Emoji';">&#9744;</span></ix:nonNumeric></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:6pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<span style="display:inline-block;width:0.34pt;"></span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:6pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:SolicitingMaterial" id="Narr_4WMCrSGR8EKfbgSBy-9ynA"><span style="font-family:'Segoe UI Emoji';">&#9744;</span></ix:nonNumeric></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:6pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:6pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:PreCommencementTenderOffer" id="Narr_X4r8q3hHOE-GMNpZsmZ4sg"><span style="font-family:'Segoe UI Emoji';">&#9744;</span></ix:nonNumeric></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:6pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:6pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:PreCommencementIssuerTenderOffer" id="Narr_76-DymO58EW4NWdiW7xlCQ"><span style="font-family:'Segoe UI Emoji';">&#9744;</span></ix:nonNumeric></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:6pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:6pt 0pt 6pt 0pt;">Securities registered pursuant to Section 12(b) of the Act:</p><a id="_b821b8ef_ba99_4233_9352_810e7a0bb8ee"></a><a id="Tc_yGLIf9jMAU2MJQKsYt-69Q_1_0"></a><a id="Tc_6vHs3x7zPEqvdHL5Eex6CQ_1_1"></a><a id="Tc_U5JakSzHSk6EUxAe3qPiOQ_1_2"></a><a id="Tc_MtfJz4DTEUixs9a8LJtWog_2_0"></a><a id="Tc_1g_-ZENcfUyu2KHDvNMXVQ_2_2"></a><a id="Tc_12CGnJyiykqjd2YG_GV3PA_3_0"></a><a id="Tc_G4vBv2A7L0OlAQqbrv1DpQ_3_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:5.75pt;padding-right:5.75pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:57.69%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:15.38%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:26.92%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:57.69%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-weight:bold;text-align:center;border-bottom:1px solid #000000;margin:0pt 0pt 1pt 0pt;">Title of each class</p></td><td style="vertical-align:bottom;width:15.38%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-weight:bold;text-align:center;border-bottom:1px solid #000000;margin:0pt 0pt 1pt 0pt;">Trading<br />Symbol(s)</p></td><td style="vertical-align:bottom;width:26.92%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-weight:bold;text-align:center;border-bottom:1px solid #000000;margin:0pt 0pt 1pt 0pt;">Name of each exchange<br />on which registered</p></td></tr><tr><td style="vertical-align:bottom;width:57.69%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;padding-left:10.8pt;text-indent:-10.8pt;margin:0pt 3.6pt 1pt 0pt;"><ix:nonNumeric contextRef="Duration_11_10_2022_To_11_10_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_ev6bO2MilkqMaKdp7dSOtA" name="dei:Security12bTitle" id="Narr_EO2x77n3wki4eO5zNOOnHQ">Shares of Class A common stock, $0.0001 par value per share</ix:nonNumeric></p></td><td style="vertical-align:bottom;width:15.38%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 1pt 0pt;"><ix:nonNumeric contextRef="Duration_11_10_2022_To_11_10_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_ev6bO2MilkqMaKdp7dSOtA" name="dei:TradingSymbol" id="Tc_ufmRMHGbSEa8iVptZFrfxQ_2_1">EVGO</ix:nonNumeric></p></td><td style="vertical-align:bottom;width:26.92%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 1pt 0pt;"><ix:nonNumeric format="ixt-sec:exchnameen" contextRef="Duration_11_10_2022_To_11_10_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_ev6bO2MilkqMaKdp7dSOtA" name="dei:SecurityExchangeName" id="Narr_aeLmOl02mkmJFSAB4RJ4Xw">The Nasdaq</ix:nonNumeric> Global Select Market </p></td></tr><tr><td style="vertical-align:bottom;width:57.69%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;padding-left:10.8pt;text-indent:-10.8pt;margin:0pt 3.6pt 1pt 0pt;"><ix:nonNumeric contextRef="Duration_11_10_2022_To_11_10_2022_us-gaap_StatementClassOfStockAxis_evgo_RedeemableWarrantsForClassCommonStockMember_iLzXOQ-tWEyaN1haO_HNkA" name="dei:Security12bTitle" id="Narr_nnxNPqyQ9km2tnxhj9TjpA">Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50</ix:nonNumeric></p></td><td style="vertical-align:bottom;width:15.38%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 1pt 0pt;"><ix:nonNumeric contextRef="Duration_11_10_2022_To_11_10_2022_us-gaap_StatementClassOfStockAxis_evgo_RedeemableWarrantsForClassCommonStockMember_iLzXOQ-tWEyaN1haO_HNkA" name="dei:TradingSymbol" id="Tc_ajFZWZC6zEaVu7jK0PCSFw_3_1">EVGOW</ix:nonNumeric></p></td><td style="vertical-align:bottom;width:26.92%;margin:0pt;padding:0pt 5.75pt 0pt 5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 1pt 0pt;"><ix:nonNumeric format="ixt-sec:exchnameen" contextRef="Duration_11_10_2022_To_11_10_2022_us-gaap_StatementClassOfStockAxis_evgo_RedeemableWarrantsForClassCommonStockMember_iLzXOQ-tWEyaN1haO_HNkA" name="dei:SecurityExchangeName" id="Narr_I_j67TS15ECrTaQ7ewaHFQ">The Nasdaq</ix:nonNumeric> Global Select Market </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:6pt 0pt 6pt 0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:6pt 0pt 6pt 0pt;">Emerging growth company <ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:EntityEmergingGrowthCompany" id="Narr_LK4-Az8t-kS-N5aOK7KizQ"><span style="font-family:'Segoe UI Emoji';">&#9746;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:6pt 0pt 0pt 0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ" name="dei:EntityExTransitionPeriod" id="Narr_ETnEpOihf0e5ydRF8JZxYA"><span style="font-family:'Segoe UI Emoji';">&#9744;</span></ix:nonNumeric></p><div style="padding-bottom:1.0px;border-bottom:1.0pt solid #000000;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-left:18pt;text-indent:-18pt;border-bottom:3.0pt solid #000000;margin:0pt;"><span style="margin-bottom:10pt;visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:76.47%;border:0;margin:30pt 11.76% 30pt 11.76%;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_0d78dd31_e348_4f31_aac4_8248e2019008"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:54pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item 1.01</b></span><b style="font-weight:bold;">Entry into a Material Definitive Agreement.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:24.5pt;margin:0pt 0pt 10pt 0pt;">On November 10, 2022, EVgo Inc. (the &#8220;Company&#8221;) entered into an Equity Distribution Agreement (the &#8220;Agreement&#8221;) with J.P. Morgan Securities LLC, Goldman Sachs &amp; Co. and Evercore Group, L.L.C. as sales agents (the &#8220;Agents&#8221;). Pursuant to the terms of the Agreement, the Company may sell from time to time through the Agents (the &#8220;Offering&#8221;), shares of the Company&#8217;s Class A common stock, par value $0.0001 per share, having an aggregate offering price of up to $200,000,000 (the &#8220;Common Stock&#8221;).<span style="white-space:pre-wrap;">   </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:24.5pt;margin:0pt 0pt 10pt 0pt;">Any Common Stock offered and sold in the Offering will be issued pursuant to the Company&#8217;s shelf registration statement on Form S-3 (Registration No.&#160;333-266753) filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on August 10, 2022 and declared effective on August 25, 2022 (the &#8220;Registration Statement&#8221;), the prospectus supplement relating to the Offering filed with the SEC on November 10, 2022 and any additional applicable prospectus supplements related to the Offering that form a part of the Registration Statement. Sales of Common Stock, if any, under the Agreement may be made by any means permitted by law, including by means of ordinary brokers&#8217; transactions, in over the counter transactions, in negotiated transactions or in any transaction that meets the definition of an &#8220;at the market offering&#8221; as defined in Rule 415 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:24.5pt;margin:0pt 0pt 10pt 0pt;">The Agreement contains customary representations, warranties and agreements by the Company, indemnification obligations of the Company and the Agents, including with respect to liabilities under the Securities Act, other obligations of the parties and termination provisions. Under the terms of the Agreement, the Company will pay the Agents a commission of up to 3% of the gross sales price of the Common Stock sold.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:10pt 0pt 10pt 0pt;">The Company plans to use the net proceeds from the Offering, after deducting the Agents&#8217; commissions and the Company&#8217;s offering expenses, for general corporate purposes, which may include, among other things, additions to working capital, repayment or refinancing of any indebtedness or other corporate obligations, financing of capital expenditures and acquisitions and investment in existing and future projects. <span style="background:#ffffff;">Pending the use of the net proceeds as described above, the Company intends to invest these net proceeds in investment-grade interest-bearing obligations, highly liquid cash equivalents, certificates of deposit, or direct or guaranteed obligations of the United States of America.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:24.5pt;margin:0pt 0pt 10pt 0pt;">The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement, a copy of which is filed herewith as Exhibit 1.1 and is incorporated by reference herein. A legal opinion relating to the Common Stock is filed herewith as Exhibit 5.1.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:justify;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_bcc2816a_2d3f_4e0f_a924_c97bd487db8a"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Item 9.01. Financial Statements and Exhibits.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;">(d) Exhibits.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:13.46%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:86.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:13.46%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-weight:bold;text-align:center;border-bottom:1px solid #000000;margin:0pt 0pt 1pt 0pt;"><b style="font-size:9pt;font-weight:bold;">Exhibit</b><b style="font-size:9pt;font-weight:bold;"><br /></b><b style="font-size:9pt;font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;width:86.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-weight:bold;text-align:center;border-bottom:1px solid #000000;margin:0pt 0pt 1pt 0pt;"><b style="font-size:9pt;font-weight:bold;">Description</b></p></td></tr><tr><td style="vertical-align:top;width:13.46%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;">1.1</p></td><td style="vertical-align:top;width:86.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;color:auto;font-family:&quot;&quot;'Times New Roman','Times','serif'&quot;&quot;;font-size:10pt;" href="evgo-20221110xex1d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-decoration-line:none;">Equity Distribution Agreement, dated November 10, 2022, by and between the Company and J.P. Morgan Securities LLC, Goldman Sachs &amp; Co. LLC and Evercore Group L.L.C.</span></a> </p></td></tr><tr><td style="vertical-align:top;width:13.46%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;">5.1</p></td><td style="vertical-align:top;width:86.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;color:auto;font-family:&quot;&quot;'Times New Roman','Times','serif'&quot;&quot;;font-size:10pt;" href="evgo-20221110xex5d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-decoration-line:none;">Opinion of Vinson &amp; Elkins L.L.P.</span></a></p></td></tr><tr><td style="vertical-align:top;width:13.46%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;">23.1</p></td><td style="vertical-align:top;width:86.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="evgo-20221110xex5d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Consent of Vinson &amp; Elkins L.L.P. (included in its opinion filed as Exhibit 5.1).</span></a></p></td></tr><tr><td style="vertical-align:top;width:13.46%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;">104</p></td><td style="vertical-align:top;width:86.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document).</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">2</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:76.47%;border:0;margin:30pt 11.76% 30pt 11.76%;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><a id="_381da0ea_1eb9_432a_a0be_1f7c9b7a6296"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;">SIGNATURES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:10pt 0pt 10pt 0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:49.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:8.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:42.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:49.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td colspan="2" style="vertical-align:top;width:50.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">EVgo Inc. </b></p></td></tr><tr><td style="vertical-align:top;width:49.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:8.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:42.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:top;width:49.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">November 10, 2022</p></td><td style="vertical-align:top;width:8.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:42.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">/s/ Olga Shevorenkova</i></p></td></tr><tr><td style="vertical-align:top;width:49.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:8.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:bottom;width:42.29%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Olga Shevorenkova</p></td></tr><tr><td style="vertical-align:top;width:49.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:8.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:42.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer</p></td></tr><tr><td style="vertical-align:top;width:49.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:8.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:42.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(Principal Financial Officer)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:10pt 0pt 10pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>evgo-20221110xex1d1.htm
<DESCRIPTION>EX-1.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 11/10/2022 09:06:54 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Exhibit 1.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:12pt;font-style:italic;font-weight:bold;">Execution Version</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">DISTRIBUTION AGREEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:12pt;">November 10, 2022</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">J.P. Morgan Securities LLC</font><font style="font-size:12pt;"><br></font><font style="font-size:12pt;">383 Madison Avenue</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">New York, New York 10179</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Evercore Group L.L.C.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">c/o Evercore Group L.L.C.</font><font style="font-size:12pt;"><br></font><font style="font-size:12pt;">55 East 52</font><sup style="font-size:9pt;vertical-align:top;">nd</sup><font style="font-size:12pt;"> Street</font><font style="font-size:12pt;"><br></font><font style="font-size:12pt;">New York, New York 10055</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Goldman Sachs &amp; Co. LLC</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">c/o Goldman Sachs &amp; Co. LLC</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">200 West Street</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">New York, New York 10282-2198</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Ladies and Gentlemen:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">EVgo Inc., a Delaware corporation (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Company</b><font style="font-size:12pt;">&#8221;), confirms its agreement with J.P. Morgan Securities LLC, Evercore Group L.L.C. and Goldman Sachs &amp; Co. LLC as Agents and/or principals under any Terms Agreement (as defined in Section&#160;1(a) below) (&#8220;</font><b style="font-size:12pt;font-weight:bold;">you</b><font style="font-size:12pt;">&#8221; or the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Agents</b><font style="font-size:12pt;">&#8221;), with respect to the issuance and sale from time to time by the Company, in the manner and subject to the terms and conditions described below in this Distribution Agreement (this &#8220;</font><b style="font-size:12pt;font-weight:bold;">Agreement</b><font style="font-size:12pt;">&#8221;), of shares of Class A common stock, $0.0001 par value per share (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Common Stock</b><font style="font-size:12pt;">&#8221;), of the Company having an aggregate Gross Sales Price (as defined in Section 2(b) below) of up to $200,000,000 (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Maximum Amount</b><font style="font-size:12pt;">&#8221;) on the terms set forth in Section&#160;1 of this Agreement. Such shares are hereinafter collectively referred to as the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Shares</b><font style="font-size:12pt;">&#8221; and are described in the Prospectus referred to below.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">The Company has filed with the Securities and Exchange Commission (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Commission</b><font style="font-size:12pt;">&#8221;) a registration statement on Form S-3 (No. 333-266753) (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">registration statement</b><font style="font-size:12pt;">&#8221;) for the registration of the Shares and other securities of the Company under the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Act</b><font style="font-size:12pt;">&#8221;); and such registration statement sets forth the terms of the offering, sale and plan of distribution of the Shares and contains additional information concerning the Company and its business. Except where the context otherwise requires, &#8220;</font><b style="font-size:12pt;font-weight:bold;">Registration Statement</b><font style="font-size:12pt;">,&#8221; as used herein, means the registration statement, as amended at the time of such registration statement&#8217;s effectiveness for purposes of Section 11 of the Act, as such section applies to the Agents, including (1) all documents filed as a part thereof or incorporated or deemed to be incorporated by reference therein and (2) any information contained or incorporated by reference in a prospectus filed with the Commission pursuant to Rule 424(b)</font></p><p style="display:none;line-height:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;white-space:pre-wrap;">under the Act, to the extent such information is deemed, pursuant to Rule 430B or Rule 430C under the Act, to be part of the registration statement at the effective time.  &#8220;</font><b style="font-size:12pt;font-weight:bold;">Basic Prospectus</b><font style="font-size:12pt;">&#8221; means the prospectus dated August 25, 2022 filed as part of the Registration Statement, including the documents incorporated by reference therein as of the date of such prospectus; &#8220;</font><b style="font-size:12pt;font-weight:bold;">Prospectus Supplement</b><font style="font-size:12pt;">&#8221; means the most recent prospectus supplement relating to the Shares, to be filed by the Company with the Commission pursuant to Rule 424(b) under the Act on or before the second business day after the date of its first use in connection with a public offering or sale of Shares pursuant hereto (or such earlier time as may be required under the Act), in the form furnished by the Company to the Agents in connection with the offering of the Shares; &#8220;</font><b style="font-size:12pt;font-weight:bold;">Prospectus</b><font style="font-size:12pt;">&#8221; means the Prospectus Supplement (and any additional prospectus supplement prepared in accordance with the provision of Section 4(h) of this Agreement and filed in accordance with the provisions of Rule 424(b)) together with the Basic Prospectus attached to or used with the Prospectus Supplement; and &#8220;</font><b style="font-size:12pt;font-weight:bold;">Permitted Free Writing Prospectus</b><font style="font-size:12pt;">&#8221; has the meaning set forth in Section&#160;3(b). Any reference herein to the Registration Statement, the Basic Prospectus, the Prospectus Supplement, the Prospectus or any Permitted Free Writing Prospectus shall, unless otherwise stated, be deemed to refer to and include the documents, if any, incorporated by reference, or deemed to be incorporated by reference, therein (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Incorporated Documents</b><font style="font-size:12pt;">&#8221;), including, unless the context otherwise requires, the documents, if any, filed as exhibits to such Incorporated Documents. Any reference herein to the terms &#8220;amend,&#8221; &#8220;amendment&#8221; or &#8220;supplement&#8221; with respect to the Registration Statement, the Basic Prospectus, the Prospectus Supplement, the Prospectus or any Permitted Free Writing Prospectus shall, unless stated otherwise, be deemed to refer to and include the filing of any document under the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (collectively, the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Exchange Act</b><font style="font-size:12pt;">&#8221;) on or after the initial effective date of the Registration Statement, or the date of the Basic Prospectus, the Prospectus Supplement, the Prospectus or such Permitted Free Writing Prospectus, as the case may be, and deemed to be incorporated therein by reference. References in this Agreement to financial statements or other information that is &#8220;contained,&#8221; &#8220;included,&#8221; &#8220;described,&#8221; &#8220;set forth&#8221; or &#8220;provided&#8221; in the Registration Statement, the Basic Prospectus, the Prospectus Supplement, the Prospectus or any Permitted Free Writing Prospectus and any similar references shall, unless stated otherwise, include any information incorporated or deemed to be incorporated by reference therein.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">The Company and the Agents agree as follows:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:14.4pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:21.6pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">1.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Issuance and Sale</u><font style="font-size:12pt;">.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(a)</font></font><font style="font-size:12pt;">Upon the basis of the representations, warranties and agreements and subject to the terms and conditions set forth herein and provided the Company provides the Agents with any due diligence materials and information reasonably requested by the Agents necessary for the Agents to satisfy its due diligence obligations, on any Exchange Business Day (as defined below) selected by the Company, the Company and the Agents shall enter into an agreement in accordance with Section 2 hereof regarding the number of Shares to be placed by the Agents, as Agents, and the manner in which and other terms upon which such placement is to occur (each such transaction being referred to as an &#8220;</font><b style="font-size:12pt;font-weight:bold;">Agency Transaction</b><font style="font-size:12pt;">&#8221;). The Company may also offer to sell the Shares directly to the Agents, as principal, in which event such parties shall enter into a separate agreement (each, a &#8220;</font><b style="font-size:12pt;font-weight:bold;">Terms Agreement</b><font style="font-size:12pt;">&#8221;) in substantially the form of Exhibit A hereto (with such changes thereto as may be agreed upon by the Company and the Agents to</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">2</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">accommodate a transaction involving additional underwriters), relating to such sale in accordance with Section 2(g) of this Agreement (each such transaction being referred to as a &#8220;</font><b style="font-size:12pt;font-weight:bold;">Principal Transaction</b><font style="font-size:12pt;">&#8221;). As used herein, (i) the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Term</b><font style="font-size:12pt;">&#8221; shall be the period commencing on the date hereof and ending on the earlier of (x) the date on which the aggregate Gross Sales Price of Shares issued and sold pursuant to this Agreement and any Terms Agreements is equal to the Maximum Amount and (y) any termination of this Agreement pursuant to Section&#160;8, (ii) an &#8220;</font><b style="font-size:12pt;font-weight:bold;">Exchange Business Day</b><font style="font-size:12pt;">&#8221; means any day during the Term that is a trading day for the Exchange other than a day on which trading on the Exchange is scheduled to close prior to its regular weekday closing time, and (iii) &#8220;</font><b style="font-size:12pt;font-weight:bold;">Exchange</b><font style="font-size:12pt;">&#8221; means the Nasdaq Global Select Market (the &#8220;Nasdaq&#8221;).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(b)</font></font><font style="font-size:12pt;">Subject to the terms and conditions set forth below, the Company appoints the Agents as Agents in connection with the offer and sale of Shares in any Agency Transactions entered into hereunder. The Agents will use commercially reasonable efforts, consistent with their normal trading and sales practices, to sell such Shares in accordance with the terms and subject to the conditions hereof and of the applicable Transaction Acceptance (as defined below). Neither the Company nor the Agents shall have any obligation to enter into an Agency Transaction. The Company shall be obligated to issue and sell through the Agents, and the Agents shall be obligated to use commercially reasonable efforts, consistent with their normal trading and sales practices and as provided herein and in the applicable Transaction Acceptance, to place Shares only if and when the Company makes a Transaction Proposal (as defined below) to the Agents related to such an Agency Transaction and a Transaction Acceptance related to such Agency Transaction has been delivered to the Company by the Agents as provided in Section 2 below.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(c)</font></font><font style="font-size:12pt;">The Agents, as Agents in any Agency Transaction, may make sales of the Shares on behalf of the Company pursuant to this Agreement by any means permitted by law, including by means of ordinary brokers&#8217; transactions, in over the counter transactions, in negotiated transactions or in any transaction that meets the definition of an &#8220;at the market offering&#8221; under Rule 415(a)(4) under the Act (such transactions are hereinafter referred to as &#8220;</font><b style="font-size:12pt;font-weight:bold;">At the Market Offerings</b><font style="font-size:12pt;">&#8221;).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(d)</font></font><font style="font-size:12pt;">If Shares are to be sold in an Agency Transaction in an At the Market Offering, the Agents will confirm in writing to the Company the number of Shares sold on any Exchange Business Day and the related Gross Sales Price and Net Sales Price (as each of such terms is defined in Section 2(b) below) no later than the opening of trading on the immediately following Exchange Business Day.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(e)</font></font><font style="font-size:12pt;">If the Company shall default on its obligation to deliver Shares to the Agents pursuant to the terms of any Agency Transaction or Terms Agreement, the Company shall (i) indemnify and hold harmless the Agents and its successors and assigns from and against any and all losses, claims, damages, liabilities and expenses arising from or as a result of such default by the Company and (ii) notwithstanding any such default, pay to the Agents the commission to which it would otherwise be entitled in connection with such sale in accordance with Section&#160;2(b) below.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">3</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(f)</font></font><font style="font-size:12pt;">The Company acknowledges and agrees that (i) there can be no assurance that the Agents will be successful in selling the Shares, (ii) the Agents shall incur no liability or obligation to the Company or any other person or entity if they do not sell Shares for any reason other than a failure by an Agent to use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable law and regulations to sell such Shares in accordance with the terms of this Agreement, and (iii) the Agents shall be under no obligation to purchase Shares on a principal basis pursuant to this Agreement, except as may otherwise be specifically agreed by the Agents and the Company in a Terms Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:14.4pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:21.6pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">2.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Transaction Acceptances and Terms Agreements</u><font style="font-size:12pt;">.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(a)</font></font><font style="font-size:12pt;">The Company may, from time to time during the Term, propose to the Agents that they enter into an Agency Transaction to be executed on a specified Exchange Business Day or over a specified period of Exchange Business Days, which proposal shall be made to the Agents by telephone or by email from any of the individuals listed as an authorized representative of the Company on Schedule A hereto to make such sales and shall set forth the information specified below (each, a &#8220;</font><b style="font-size:12pt;font-weight:bold;">Transaction Proposal</b><font style="font-size:12pt;">&#8221;). If the Agents agrees to the terms of such proposed Agency Transaction or if the Company and the Agents mutually agree to modified terms for such proposed Agency Transaction, then the Agents shall promptly deliver to the Company by email a notice (each, a &#8220;</font><b style="font-size:12pt;font-weight:bold;">Transaction Acceptance</b><font style="font-size:12pt;">&#8221;) confirming the terms of such proposed Agency Transaction as set forth in such Transaction Proposal or setting forth the modified terms for such proposed Agency Transaction as agreed by the Company and the Agents, as the case may be, whereupon such Agency Transaction shall become a binding agreement between the Company and the Agents. Each Transaction Proposal shall specify:</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(i)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">the Exchange Business Day(s) on which the Shares subject to such Agency Transaction are intended to be sold (each, a </font><font style="font-family:'(normal text)';font-size:12pt;">&#8220;</font><b style="font-size:12pt;font-weight:bold;">Sale Date</b><font style="font-size:12pt;">&#8221;);</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(ii)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">the maximum number of Shares to be sold by the Agents (the </font><font style="font-family:'(normal text)';font-size:12pt;">&#8220;</font><b style="font-size:12pt;font-weight:bold;">Specified Number of Shares</b><font style="font-size:12pt;">&#8221;) on, or over the course of, such Sale Date(s), or as otherwise agreed between the Company and Agents and documented in the relevant Transaction Acceptance; and</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(iii)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">the lowest price, if any, at which the Company is willing to sell Shares on each such Sale Date or a formula pursuant to which such lowest price shall be determined (each, a </font><font style="font-family:'(normal text)';font-size:12pt;">&#8220;</font><b style="font-size:12pt;font-weight:bold;">Floor Price</b><font style="font-size:12pt;">&#8221;); and</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(iv)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">if other than 3% of the Gross Sales Price, the Agents</font><font style="font-family:'(normal text)';font-size:12pt;">&#8217;</font><font style="font-size:12pt;"> discount or commission.</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 72pt;"><font style="font-size:12pt;">A Transaction Proposal shall not set forth a Specified Number of Shares that, when added to the aggregate number or aggregate Gross Sales Price of Shares previously purchased and to be purchased pursuant to pending Transaction Acceptances (if any) hereunder and any Terms Agreements, results or could result in a total number of shares that exceeds the Maximum Amount of Shares nor shall it set forth a Floor Price which is lower than the minimum price authorized from time to time by the Company&#8217;s board of directors or, if permitted by applicable</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">4</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 72pt;"><font style="font-size:12pt;">law and the Company&#8217;s charter and by-laws, a duly authorized committee thereof. The Company shall have responsibility for maintaining records with respect to the aggregate number and aggregate Gross Sales Price of Shares sold and for otherwise monitoring the availability of Shares for sale under the Registration Statement and for insuring that the aggregate number and aggregate Gross Sales Price of Shares offered and sold does not exceed, and the price at which any Shares are offered or sold is not lower than, the aggregate number and aggregate Gross Sales Price of Shares and the minimum price authorized from time to time by the Company&#8217;s board of directors or, if permitted by applicable law and the Company&#8217;s charter and by-laws, a duly authorized committee thereof. In the event that more than one Transaction Acceptance with respect to any Sale Date(s) is delivered by the Agents to the Company, the latest Transaction Acceptance shall govern any sales of Shares for the relevant Sale Date(s), except to the extent of any action occurring pursuant to a prior Transaction Acceptance and prior to the delivery to the Company of the latest Transaction Acceptance. The Company or the Agents may, upon notice to the other such party by telephone (confirmed promptly by e-mail), suspend or terminate the offering of the Shares pursuant to Agency Transactions for any reason; </font><i style="font-size:12pt;font-style:italic;">provided</i><font style="font-size:12pt;">, </font><i style="font-size:12pt;font-style:italic;">however</i><font style="font-size:12pt;">, that such suspension or termination shall not affect or impair the parties&#8217; respective obligations with respect to the Shares sold hereunder prior to the giving of such notice or their respective obligations under any Terms Agreement. Notwithstanding the foregoing, if the terms of any Agency Transaction contemplate that Shares shall be sold on more than one Sale Date, then the Company and the Agents shall mutually agree to such additional terms and conditions as they deem reasonably necessary in respect of such multiple Sale Dates, and such additional terms and conditions shall be set forth in or confirmed by, as the case may be, the relevant Transaction Acceptance and be binding to the same extent as any other terms contained therein.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(b)</font></font><font style="font-size:12pt;">The Sale Date(s) in respect of the Shares deliverable pursuant to any Transaction Acceptance shall be set forth in or confirmed by, as the case may be, the applicable Transaction Acceptance. Except as otherwise agreed between the Company and the Agents, the Agents&#8217; commission for any Shares sold through the Agents pursuant to this Agreement shall be a percentage, not to exceed 3%, of the actual sales price of such Shares (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Gross Sales Price</b><font style="font-size:12pt;">&#8221;), which commission shall be as set forth in or confirmed by, as the case may be, the applicable Transaction Acceptance; </font><i style="font-size:12pt;font-style:italic;">provided</i><font style="font-size:12pt;">, </font><i style="font-size:12pt;font-style:italic;">however</i><font style="font-size:12pt;">, that such commission shall not apply when the Agents acts as principal, in which case such commission or a discount shall be set forth in the applicable Terms Agreement. Notwithstanding the foregoing, in the event the Company engages the Agents for a sale of Shares in an Agency Transaction that would constitute a &#8220;distribution,&#8221; within the meaning of Rule 100 of Regulation M under the Exchange Act or a &#8220;block&#8221; within the meaning of Rule 10b-18(a)(5) under the Exchange Act, the Company will provide the Agents, at the Agents&#8217; request and upon reasonable advance notice to the Company, on or prior to the Settlement Date (defined below) the opinions of counsel, accountants&#8217; letters and officers&#8217; certificates pursuant to Section 6 hereof, each dated the Settlement Date, and such other documents and information as the Agents shall reasonably request, and the Company and the Agents will agree to compensation that is customary for the Agents with respect to such transaction. The Gross Sales Price less the Agents&#8217; commission and after deduction for any</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">5</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">transaction fees, transfer taxes or similar taxes or fees imposed by any governmental, regulatory or self-regulatory organization in respect of the sale of the applicable Shares is referred to herein at the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Net Sales Price</b><font style="font-size:12pt;">.&#8221;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(c)</font></font><font style="font-size:12pt;">Payment of the Net Sales Price for Shares sold by the Company on any Sale Date pursuant to a Transaction Acceptance shall be made to the Company by wire transfer of immediately available funds to the account of the Company (which the Company shall provide to the Agents at least one Exchange Business Day prior to the applicable Agency Settlement Date (as defined below)) against delivery of such Shares to the Agents&#8217; account, or an account of the Agents&#8217; designee, at The Depository Trust Company through its Deposit and Withdrawal at Custodian System (&#8220;</font><b style="font-size:12pt;font-weight:bold;">DWAC</b><font style="font-size:12pt;">&#8221;) or by such other means of delivery as may be agreed to by the Company and the Agents. Such payment and delivery shall be made at or about 10:00 a.m. (New York City time) on the second Exchange Business Day (or such other day as may, from time to time, become standard industry practice for settlement of such a securities issuance or as agreed to by the Company and the Agents) following each Sale Date (each, an &#8220;</font><b style="font-size:12pt;font-weight:bold;">Agency Settlement Date</b><font style="font-size:12pt;">&#8221;).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(d)</font></font><font style="font-size:12pt;">If, as set forth in or confirmed by, as the case may be, the related Transaction Acceptance, a Floor Price has been agreed to by the parties with respect to a Sale Date, and the Agents thereafter determines and notifies the Company that the Gross Sales Price for such Agency Transaction would not be at least equal to such Floor Price, then the Company shall not be obligated to issue and sell through the Agents, and the Agents shall not be obligated to place, the Shares proposed to be sold pursuant to such Agency Transaction on such Sale Date, unless the Company and the Agents otherwise agree in writing.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(e)</font></font><font style="font-size:12pt;">If either party has reason to believe that the exemptive provisions set forth in Rule 101(c)(1) of Regulation M under the Exchange Act are not satisfied with respect to the Shares, it shall promptly notify the other party and sales of the Shares under this Agreement, any Transaction Acceptance or any Terms Agreement shall be suspended until that or other exemptive provisions have been satisfied in the judgment of each party. On or prior to the delivery of a prospectus that is required (whether physically or through compliance with Rule 172 under the Act or any similar rule) in connection with the offering or sale of the Shares, the Company shall calculate the average daily trading volume (as defined under &#8220;</font><b style="font-size:12pt;font-weight:bold;">ADTV</b><font style="font-size:12pt;">&#8221; by Rule 100 of Regulation M under the Exchange Act) of the Common Stock based on market data provided by Bloomberg L.P. or such other sources as agreed upon by the Company and the Agents.</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(f)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(i) If the Company wishes to issue and sell the Shares pursuant to this Agreement but other than as set forth in Section 2(a) of this Agreement, it will notify the Agents of the proposed terms of the Principal Transaction. If the Agents, acting as principal, wish to accept such proposed terms (which they may decline to do for any reason in their sole discretion) or, following discussions with the Company, wish to accept amended terms, the Company and the Agents shall enter into a Terms Agreement setting forth the terms of such Principal Transaction.</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 72pt;"><font style="display:inline-block;text-indent:0pt;width:18pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(ii)</font></font><font style="font-size:12pt;">The terms set forth in a Terms Agreement shall not be binding on the Company or the Agents unless and until the Company and the Agent have each</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">6</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 72pt;"><font style="font-size:12pt;">executed and delivered such Terms Agreement accepting all of the terms of such Terms Agreement. In the event of a conflict between the terms of this Agreement and the terms of a Terms Agreement, the terms of such Terms Agreement shall control.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(g)</font></font><font style="font-size:12pt;">Each sale of the Shares to an Agent in a Principal Transaction shall be made in accordance with the terms of this Agreement and a Terms Agreement, which shall provide for the sale of such Shares to, and the purchase thereof by, the Agent. A Terms Agreement may also specify certain provisions relating to the reoffering of such Shares by the Agent. The commitment of the Agent to purchase the Shares pursuant to any Terms Agreement shall be deemed to have been made on the basis of the representations, warranties and agreements of the Company contained, and shall be subject to the terms and conditions set forth, in this Agreement and such Terms Agreement. Any such Terms Agreement shall specify the number of the Shares to be purchased by the Agent pursuant thereto, the price to be paid to the Company for such Shares, any provisions relating to rights of, and default by, underwriters, if any, acting together with the Agent in the reoffering of the Shares, and the time and date (each such time and date being referred to herein as a &#8220;</font><b style="font-size:12pt;font-weight:bold;">Principal Settlement Date</b><font style="font-size:12pt;">&#8221;; and, together with any Agency Settlement Date, a &#8220;</font><b style="font-size:12pt;font-weight:bold;">Settlement Date</b><font style="font-size:12pt;">&#8221;) and place of delivery of and payment for such Shares.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(h)</font></font><font style="font-size:12pt;">Notwithstanding any other provision of this Agreement, the Company shall not offer, sell or deliver, or request the offer or sale, of any Shares pursuant to this Agreement (whether in an Agency Transaction or a Principal Transaction) and, by notice to the Agents given by telephone (confirmed promptly by email), shall cancel any instructions for the offer or sale of any Shares, and the Agents shall not be obligated to offer or sell any Shares, (i)&#160;during any period in which the Company is, or could be deemed to be, in possession of material non-public information or (ii)&#160;from the date two weeks prior to the date on which the Company expects to issue a press release containing, or shall otherwise publicly announce, its earnings, revenues or other financial results (an &#8220;</font><b style="font-size:12pt;font-weight:bold;">Earnings Announcement</b><font style="font-size:12pt;">&#8221;) through and including the time that is 24 hours after the time that the Company files a Quarterly Report on Form 10-Q or an Annual Report on Form 10-K that includes consolidated financial statements as of and for the same period or periods, as the case may be, covered by such Earnings Announcement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(i)</font></font><font style="font-size:12pt;">The Company agrees that any offer to sell, any solicitation of an offer to buy, or any sales of Shares by the Company shall be effected only by or through one Agents on any Exchange Business Day.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(j)</font></font><font style="font-size:12pt;">Anything in this Agreement to the contrary notwithstanding, the Company shall not authorize the issuance and sale of, and the Agents, as sales Agents, shall not be obligated to use its commercially reasonable efforts, consistent with its normal trading and sales practices, to sell, any Shares at a price lower than the minimum price, or in a number or with an aggregate gross or Net Sales Price in excess of the number or aggregate gross or Net Sales Price, as the case may be, authorized from time to time to be issued and sold under this Agreement and any Terms Agreement, in each case by the Company&#8217;s board of directors or, if permitted by applicable law and the Company&#8217;s charter and by-laws, a duly authorized committee thereof, or in a number in excess of the number of Shares approved for listing on the Exchange, or in excess of the number or amount of Shares available for issuance on the Registration Statement or as to which the Company has paid the applicable registration fee, it being understood and agreed by</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">7</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">the parties hereto that compliance with any such limitations shall be the sole responsibility of the Company.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:14.4pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:21.6pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">3.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Representations, Warranties and Agreements of the Company</u><font style="font-size:12pt;white-space:pre-wrap;">.  The Company represents and warrants to, and agrees with, the Agents, on and as of (i) the date hereof, (ii) each date on which the Company receives a Transaction Acceptance (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Time of Acceptance</b><font style="font-size:12pt;">&#8221;), (iii) each date on which the Company executes and delivers a Terms Agreement, (iv) each Time of Sale (as defined in Section 3(a)), (v) each Settlement Date and (vi) each Bring-Down Delivery Date (as defined in Section 6(b)) (each such date listed in (i) through (vi), a &#8220;</font><b style="font-size:12pt;font-weight:bold;">Representation Date</b><font style="font-size:12pt;">&#8221;), as follows:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(a)</font></font><font style="font-size:12pt;">The Registration Statement has been declared effective by the Commission, there is no order preventing or suspending the use of the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus, and, to the knowledge of the Company, no proceeding for that purpose or pursuant to Section&#160;8A of the Act against the Company or related to the offering has been initiated or threatened by the Commission; no notice of objection of the Commission to the use of such Registration Statement pursuant to Rule 401(g)(2) under the Act has been received by the Company; the Registration Statement complied when it initially became effective, complies as of the date hereof and, as then amended or supplemented, as of each other Representation Date will comply, in all material respects, with the requirements of the Act; the conditions to the use of Form S-3 in connection with the offering and sale of the Shares as contemplated hereby have been satisfied; the Registration Statement meets, and the offering and sale of the Shares as contemplated hereby comply with, the requirements of Rule 415 under the Act (including, without limitation, Rule&#160;415(a)(5)); the Prospectus complied or will comply, at the time it was or will be filed with the Commission, and will comply, as then amended or supplemented, as of each Representation Date, in all material respects, with the requirements of the Act; the Registration Statement did not, as of the time of its initial effectiveness, and does not or will not, as then amended or supplemented, as of each Representation Date, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; as of each Representation Date, the Prospectus, as then amended or supplemented, together with all of the then issued Permitted Free Writing Prospectuses, if any, will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;</font><i style="font-size:12pt;font-style:italic;"> provided, however, </i><font style="font-size:12pt;">that the Company makes no representation or warranty with respect to any statement in or omission from the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus made in reliance upon and in conformity with information concerning the Agents and furnished in writing by or on behalf of the Agents expressly for use in the Registration Statement, the Prospectus or such Permitted Free Writing Prospectus (it being understood that such information consists solely of the information specified in Section 9(b)). As used herein, &#8220;</font><b style="font-size:12pt;font-weight:bold;">Time of Sale</b><font style="font-size:12pt;">&#8221; means (i)&#160;with respect to each offering of Shares pursuant to this Agreement, the time of the Agents&#8217;s initial entry into contracts with investors for the sale of such Shares and (ii)&#160;with respect to each offering of Shares pursuant to any relevant Terms Agreement, the time of sale of such Shares.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(b)</font></font><font style="font-size:12pt;">The Company is, as of the date hereof, and will be for at least the period specified in Rule 164(e)(2), an &#8220;ineligible issuer&#8221; in connection with the offering pursuant to Rules 165, 405 and 433 under the Act. Prior to the execution of this Agreement, the Company has not,</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">8</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">directly or indirectly, offered or sold any of the Shares by means of any &#8220;prospectus&#8221; (within the meaning of the Act) or used any &#8220;prospectus&#8221; (within the meaning of the Act) in connection with the offer or sale of the Shares, in each case other than the Basic Prospectus. The Company represents and agrees that, unless it obtains the prior consent of the Agents, until the termination of this Agreement, it has not made and will not make any offer relating to the Shares that would constitute an &#8220;issuer free writing prospectus&#8221; (as defined in Rule 433 under the Act) or that would otherwise constitute a &#8220;free writing prospectus&#8221; (as defined in Rule 405 under the Act) other than any Permitted Free Writing Prospectus. Any such free writing prospectus relating to the Shares consented to by the Agents (including any Free Writing Prospectus prepared by the Company solely for use in connection with the offering contemplated by a particular Terms Agreement) is hereinafter referred to as a &#8220;</font><b style="font-size:12pt;font-weight:bold;">Permitted Free Writing Prospectus</b><font style="font-size:12pt;">&#8221;. The Company has complied and will comply in all material respects with the requirements of Rule 433 under the Act applicable to any Permitted Free Writing Prospectus, including timely filing with the Commission where required, legending and record keeping. The conditions set forth in one or more of subclauses (i) through (iv), inclusive, of Rule 433(b)(1) under the Act are satisfied, and the registration statement relating to the offering of the Shares contemplated hereby, as initially filed with the Commission, includes a prospectus that, other than by reason of Rule 433 under the Act, satisfies the requirements of Section 10 of the Act; at any time the Company uses any Permitted Free Writing Prospectus, the Company will not be disqualified, by reason of Rule 164(f) or (g) under the Act, from using, in connection with the offer and sale of the Shares, &#8220;free writing prospectuses&#8221; (as defined in Rule 405 under the Act) pursuant to Rules 164 and 433 under the Act; at any time the Company uses any Permitted Free Writing Prospectus, the Company will not be, as of each eligibility determination date for purposes of Rules 164 and 433 under the Act with respect to the offering of the Shares contemplated by the Registration Statement and this Agreement, an &#8220;ineligible issuer&#8221;. The Company has paid or, no later than the business day after the date of this Agreement, will pay the registration fee for the offering of the Maximum Amount of Shares pursuant to Rule 457 under the Act.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(c)</font></font><font style="font-size:12pt;">The Incorporated Documents, when they were filed with the Commission (or, if any amendment with respect to any such document was filed, when such amendment was filed), conformed in all material respects to the requirements of the Act or the Exchange Act, as applicable, and none of such documents contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading; and any further documents so filed during the Term and incorporated by reference in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus, when such documents become effective or are filed with the Commission, as the case may be, will conform in all material respects to the requirements of the Act or the Exchange Act, as applicable, and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(d)</font></font><font style="font-size:12pt;">The financial statements (including the related notes thereto) of the Company and its consolidated subsidiaries included or incorporated by reference in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus comply in all material respects with the applicable accounting requirements of the Act and the Exchange Act, as applicable, and present fairly, in all material respects, the consolidated financial position of the Company and its</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">9</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">consolidated subsidiaries as of the dates indicated and the results of their operations and the changes in their cash flows for the periods specified; such financial statements have been prepared in conformity with generally accepted accounting principles (&#8220;</font><b style="font-size:12pt;font-weight:bold;">GAAP</b><font style="font-size:12pt;">&#8221;) in the United States applied on a consistent basis throughout the periods covered thereby, except in the case of unaudited interim financial statements, which are subject to normal year-end adjustments and do not contain certain footnotes as permitted by the applicable rules of the Commission and as otherwise stated therein, and any supporting schedules included or incorporated by reference in the Registration Statement present fairly in all material respects the information required to be stated therein; and the other financial information included or incorporated by reference in the Registration Statement and the Prospectus has been derived from the accounting records of the Company and its consolidated subsidiaries and presents fairly in all material respects the information shown thereby; all disclosures included in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus regarding &#8220;non-GAAP financial measures&#8221; (as such term is defined by the rules and regulations of Commission) comply in all material respects with Regulation G of the Exchange Act and Item 10 of Regulation S-K of the Act, to the extent applicable.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(e)</font></font><font style="font-size:12pt;">Since the date of the most recent financial statements of the Company included or incorporated by reference in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus, (i)&#160;there has not been any material change in the capital stock (other than the issuance of shares of Class A Common Stock upon exercise of stock options and warrants described as outstanding in, and the grant of options and awards under existing equity incentive plans described in, the Registration Statement and the Prospectus, and the issuance of Shares pursuant to this Agreement), material change in the short-term debt or long-term debt of the Company or any of its subsidiaries, or any dividend or distribution of any kind declared other than ordinary or customary dividends or distributions, set aside for payment, paid or made by the Company on any class of capital stock, or any material adverse change, or any development involving a prospective material adverse change, in or affecting the business, properties, management, financial position, stockholders&#8217; equity, results of operations or prospects of the Company and its subsidiaries taken as a whole; (ii) neither the Company nor any of its subsidiaries has entered into any transaction or agreement (not in the ordinary course of business) that is material to the Company and its subsidiaries taken as a whole or incurred any liability or obligation (not in the ordinary course of business), direct or contingent, that is material to the Company and its subsidiaries taken as a whole; and (iii) neither the Company nor any of its subsidiaries has sustained any loss or interference with its business that is material to the Company and its subsidiaries taken as a whole and that is either from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor disturbance or dispute or any action, order or decree of any court or arbitrator or governmental or regulatory authority, except in each case as otherwise disclosed in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(f)</font></font><font style="font-size:12pt;">The Company and each of its subsidiaries have been duly organized and are validly existing and in good standing under the laws of their respective jurisdictions of organization, are duly qualified to do business and are in good standing in each jurisdiction in which their respective ownership or lease of property or the conduct of their respective businesses requires such qualification, and have all power and authority necessary to own or hold their respective properties and to conduct the businesses in which they are engaged, except</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">10</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">where the failure to be so qualified or in good standing or have such power or authority would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. &#8220;</font><b style="font-size:12pt;font-weight:bold;">Material Adverse Effect</b><font style="font-size:12pt;">&#8221; means a material adverse change to the business, properties, management, financial position, stockholders&#8217; equity, results of operations or prospects of the Company and its subsidiaries taken as a whole or on the performance by the Company of its obligations under this Agreement or any Terms Agreement. The Company does not own or control, directly or indirectly, any corporation, association or other entity other than the subsidiaries listed in Exhibit D hereto.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(g)</font></font><font style="font-size:12pt;">The Company has an authorized capitalization as set forth in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus; all the outstanding shares of capital stock of the Company have been duly and validly authorized and issued and are fully paid and non-assessable and are not subject to any pre-emptive or similar rights that have not been duly waived or satisfied; except as described in or expressly contemplated by the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus, there are no outstanding rights (including, without limitation, pre-emptive rights that have not been duly waived or satisfied), warrants or options to acquire, or instruments convertible into or exchangeable for, any shares of capital stock or other equity interest in the Company or any of its subsidiaries, or any contract, commitment, agreement, understanding or arrangement of any kind relating to the issuance of any capital stock of the Company or any such subsidiary, any such convertible or exchangeable securities or any such rights, warrants or options; the capital stock of the Company conforms in all material respects to the description thereof contained in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus; and all the outstanding shares of capital stock or other equity interests of each subsidiary owned, directly or indirectly, by the Company have been duly and validly authorized and issued, are fully paid and non-assessable and are owned directly or indirectly by the Company, free and clear of any lien, charge, encumbrance, security interest, restriction on voting or transfer or any other claim of any third party.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(h)</font></font><font style="font-size:12pt;">With respect to the stock options (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Stock Options</b><font style="font-size:12pt;">&#8221;) granted pursuant to the stock-based compensation plans of the Company and its subsidiaries (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Company Stock Plans</b><font style="font-size:12pt;">&#8221;), (i) each Stock Option intended to qualify as an &#8220;incentive stock option&#8221; under Section&#160;422 of the Internal Revenue Code of 1986, as amended (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Code</b><font style="font-size:12pt;">&#8221;) so qualifies, (ii) each grant of a Stock Option was duly authorized no later than the date on which the grant of such Stock Option was by its terms to be effective by all necessary corporate action, including, as applicable, approval by the board of directors of the Company (or a duly constituted and authorized committee thereof) and any required stockholder approval by the necessary number of votes or written consents, and the award agreement governing such grant (if any) was duly executed and delivered by each party thereto, (iii) each such grant was made in accordance with the terms of the Company Stock Plans, the Exchange Act and all other applicable laws and regulatory rules or requirements, including the rules of the Nasdaq, and (iv)&#160;each such grant was properly accounted for in accordance with GAAP in the financial statements (including the related notes) of the Company and disclosed in the Company&#8217;s filings with the Commission in accordance with the Exchange Act and all other applicable laws. The Company has not knowingly granted, and there is no and has been no policy or practice of the Company of granting, Stock Options prior to, or otherwise coordinating the grant of Stock Options with, the</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">11</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">release or other public announcement of material information regarding the Company or its subsidiaries or their results of operations or prospects.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(i)</font></font><font style="font-size:12pt;">This Agreement has been duly authorized, executed and delivered by the Company and any Terms Agreement will have been duly authorized, executed and delivered by the Company.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(j)</font></font><font style="font-size:12pt;">The Shares to be issued and sold by the Company hereunder or under any Terms Agreement have been duly authorized by the Company and, when issued and delivered and paid for as provided herein or in any Terms Agreement, as the case may be, will be duly and validly issued, will be fully paid and nonassessable and will conform to the description thereof in the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus; and the issuance and sale of the Shares are not and will not be subject to any preemptive or similar rights.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(k)</font></font><font style="font-size:12pt;">The Company has full right, power and authority to execute and deliver this Agreement and any Terms Agreement and perform its obligations hereunder or thereunder, including the Company&#8217;s issuance, sale and delivery of the Shares as provided herein and therein; and all action required to be taken for the due and proper authorization, execution and delivery by each of the Company of this Agreement and any Terms Agreement and the consummation by it of the transactions contemplated hereby and thereby has been duly and validly taken (or, in the case of any Terms Agreement, such action will have been duly and validly authorized).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(l)</font></font><font style="font-size:12pt;">This Agreement conforms and each Terms Agreement will conform in all material respects to the description thereof contained in the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(m)</font></font><font style="font-size:12pt;">Neither the Company nor any of its subsidiaries is (i)&#160;in violation of its charter or by-laws or similar organizational documents; (ii)&#160;in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any property or asset of the Company or any of its subsidiaries is subject; or (iii) in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of clauses (ii) and (iii) above, for any such default or violation that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(n)</font></font><font style="font-size:12pt;">The execution, delivery and performance by the Company of this Agreement and any Terms Agreement, the issuance and sale of the Shares, the compliance by the Company with the terms hereof and of any Terms Agreement and the consummation of the transactions contemplated hereby or by any Terms Agreement will not (i) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company or any of its subsidiaries pursuant to, any indenture, mortgage, deed of trust, loan</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">12</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company or any of its subsidiaries is subject, (ii) result in any violation of the provisions of the charter or by-laws or other organizational documents of the Company or any of its subsidiaries or (iii) result in the violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of clauses (i) and (iii) above, for any such conflicts, breaches, violations or defaults that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(o)</font></font><font style="font-size:12pt;">No consent, approval, authorization, order, license, registration or qualification of or with any court or arbitrator or governmental or regulatory authority is required for the execution, delivery and performance by the Company of this Agreement or any Terms Agreement, the issuance and sale of the Shares, compliance by the Company with the terms of this Agreement or of any Terms Agreement and the consummation of the transactions contemplated by this Agreement or any Terms Agreement, except as have been made or obtained, except as may be required by and made in accordance with or obtained under state securities laws or regulations, and except for such filings of Permitted Free Writing Prospectuses and any amendments or supplements to the Registration Statement or the Prospectus or any documents incorporated or deemed to be incorporated by reference therein as may be required by the Act or the Exchange Act from time to time, and except for such filings as the Exchange may require from time to time.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(p)</font></font><font style="font-size:12pt;">Except as described in the Registration Statement and the Prospectus, there are no legal, governmental or regulatory investigations, actions, demands, claims, suits, arbitrations, inquiries or proceedings (&#8220;</font><b style="font-size:12pt;font-weight:bold;">Actions</b><font style="font-size:12pt;">&#8221;) pending to which the Company or any of its subsidiaries is or may be a party or to which any property of the Company or any of its subsidiaries is or may be the subject that, individually or in the aggregate, if determined adversely to the Company or any of its subsidiaries, would reasonably be expected to have a Material Adverse Effect; to the knowledge of the Company, no such Actions are threatened or contemplated by any governmental or regulatory authority or threatened by others; and (i) there are no current or pending Actions that are required under the Securities Act to be described in the Registration Statement or the Prospectus that are not so described in the Registration Statement and the Prospectus and (ii) there are no statutes, regulations or contracts or other documents that are required under the Securities Act to be filed as exhibits to the Registration Statement or described in the Registration Statement or the Prospectus that are not so filed as exhibits to the Registration Statement or described in the Registration Statement and the Prospectus.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(q)</font></font><font style="font-size:12pt;">KPMG LLP, whose report on the consolidated financial statements of the Company and its consolidated subsidiaries is included or incorporated by reference in the Registration Statement and the Prospectus, is an independent registered public accounting firm with respect to the Company and its subsidiaries within the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight Board (&#8220;</font><b style="font-size:12pt;font-weight:bold;">PCAOB</b><font style="font-size:12pt;">&#8221;) and as required by the Act. Each other independent registered public accounting firm, if any, that has certified or reported on any other financial statements included or incorporated by reference in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus is an independent registered public accounting firm with respect to the Company and its</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">13</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">subsidiaries or other appropriate entity, as applicable, within the applicable rules and regulations adopted by the Commission and the PCAOB and as required by the Act.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(r)</font></font><font style="font-size:12pt;">Except as described in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus; (i) the Company and its subsidiaries own or have licensed adequate rights to use all patents, trademarks, service marks, trade names, domain names, copyrights, know-how, trade secrets, systems, procedures, proprietary and/or or confidential information and all other worldwide intellectual property and industrial property (collectively, &#8220;</font><b style="font-size:12pt;font-weight:bold;">Intellectual Property</b><font style="font-size:12pt;">&#8221;) used in the conduct of their respective businesses, except where the failure to have any of the foregoing would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; (ii) the Company&#8217;s and its subsidiaries&#8217; conduct of their respective businesses does not infringe, misappropriate, dilute or otherwise violate any Intellectual Property of any person, except as had not and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect; (iii) the Company and its subsidiaries have not received any written notice of any claim relating to infringement, misappropriation, dilution or other violation of Intellectual Property owned by a third party that has not been fully resolved, and that, if the subject of an unfavorable decision, ruling or finding, would, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect; (iv) to the knowledge of the Company, the Intellectual Property owned by or exclusively or co-exclusively licensed to the Company and its subsidiaries is not being infringed, misappropriated, diluted or otherwise violated by any person, except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect; and </font>(v) t<font style="font-size:12pt;">he Company or one of its subsidiaries exclusively owns all material Intellectual Property owned or purported to be owned by the Company or its subsidiaries.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(s)</font></font><font style="font-size:12pt;">The Company and its subsidiaries have good and marketable title in fee simple (in the case of real property) to, or have valid rights to lease or otherwise use, all items of real and personal property that are material to the respective businesses of the Company and its subsidiaries, in each case free and clear of all liens, encumbrances, claims and defects and imperfections of title except those that (i)&#160;do not materially interfere with the use made and proposed to be made of such property by the Company and its subsidiaries or (ii) would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(t)</font></font><font style="font-size:12pt;">No relationship, direct or indirect, exists between or among the Company or any of its subsidiaries, on the one hand, and the directors, officers, stockholders or other affiliates of the Company or any of its subsidiaries, on the other, that is required by the Act to be described in the Registration Statement or the Prospectus and that is not so described in such documents or a Permitted Free Writing Prospectus.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(u)</font></font><font style="font-size:12pt;">The Company is not and, immediately after giving effect to the offering and sale of the Shares and the application of the proceeds thereof as described in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus, will not be required to register as an &#8220;investment company&#8221; and is not an entity &#8220;controlled by&#8221; an &#8220;investment company&#8221; within the meaning of the Investment Company Act of 1940, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Investment Company Act</b><font style="font-size:12pt;">&#8221;).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">14</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(v)</font></font><font style="font-size:12pt;">The Company and its subsidiaries have paid all U.S. federal, state and local and non-U.S. taxes that are due and payable and filed all tax returns required to be filed through the date hereof (taking into account any valid extensions of time to file), except in any case (A) for such taxes, if any, as are being contested in good faith and as to which adequate reserves have been established by the Company or its subsidiaries or (B) in which the failure to pay would not, individually or in the aggregate, if determined adversely to the Company or any of its subsidiaries, reasonably be expected to have a Material Adverse Effect. Except as would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect or otherwise disclosed in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus, there is no tax deficiency that has been, or would reasonably be expected to be, asserted against the Company or any of its subsidiaries or any of their respective properties or assets. The charges, accruals and reserves on the books of the Company in respect of any income and corporation tax liability for any years not finally determined are, in conformity with GAAP, adequate to meet any assessments or re-assessments for additional income tax for any years not finally determined, except to the extent of any inadequacies that would not reasonably be expected to result in a Material Adverse Effect.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(w)</font></font><font style="font-size:12pt;">The Company and its subsidiaries possess all licenses, sub-licenses, certificates, permits and other authorizations issued by, and have made all declarations and filings with, the appropriate federal, state, local or foreign governmental or regulatory authorities that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus, except where the failure to possess or make the same would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and except as described in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus, neither the Company nor any of its subsidiaries has received notice of any revocation or modification of any such license, sub-license, certificate, permit or authorization or has any reason to believe that any such license, sub-license, certificate, permit or authorization will not be renewed in the ordinary course, except for any of the foregoing that would not reasonably be expected to have a Material Adverse Effect.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(x)</font></font><font style="font-size:12pt;">No labor disturbance by or dispute with employees of the Company or any of its subsidiaries exists or, to the knowledge of the Company, is threatened, and the Company is not aware of any existing labor disturbance by, or dispute with, the employees of any of its or its subsidiaries&#8217; principal suppliers, contractors or customers, except as would not reasonably be expected to have a Material Adverse Effect.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(y)</font></font><font style="font-size:12pt;">(i) The Company and its subsidiaries (x) are in compliance with all, and have not violated any, applicable federal, state, local and foreign laws (including common law), rules, regulations, ordinances, codes, requirements, decisions, judgments, decrees, orders and other legally enforceable requirements relating to pollution or the protection of human health or safety, the environment, including natural resources, or the generation use, treatment, storage, or disposal of hazardous or toxic substances or wastes, pollutants or contaminants (collectively, &#8220;</font><b style="font-size:12pt;font-weight:bold;">Environmental Laws</b><font style="font-size:12pt;">&#8221;); (y) have received and are in compliance with all, and have not violated any, permits, licenses, certificates or other authorizations or approvals required of them under any Environmental Laws to conduct their respective businesses; and (z) have not received notice of any actual or potential liability or obligation under or relating to, or any actual or</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">15</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">potential violation of, any Environmental Laws, including for the investigation or remediation of any disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants, and have no knowledge of any event or condition that would reasonably be expected to result in any such notice; (ii) there are no costs or liabilities associated with Environmental Laws of or relating to the Company or its subsidiaries, except in the case of each of (i) and (ii) above, for any such matter as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and (iii) except as described in the Registration Statement, the Prospectus </font><font style="font-size:12pt;">or any Permitted Free Writing Prospectus</font><font style="font-size:12pt;">, (x) there is no proceeding that is pending, or, to the knowledge of the Company, contemplated, against the Company or any of its subsidiaries under any Environmental Laws in which a governmental entity is also a party, other than such proceeding regarding which it is reasonably believed no monetary sanctions of $300,000 or more will be imposed, (y) the Company and its subsidiaries are not aware of any facts or issues regarding compliance with Environmental Laws, or liabilities or other obligations under Environmental Laws or concerning hazardous or toxic substances or wastes, pollutants or contaminants, that would reasonably be expected to have a material effect on the capital expenditures, earnings or competitive position of the Company and its subsidiaries, and (z) none of the Company or its subsidiaries anticipates material capital expenditures relating to any Environmental Laws.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(z)</font></font><font style="font-size:12pt;"> (i) Each employee benefit plan, within the meaning of Section&#160;3(3) of the Employee Retirement Income Security Act of 1974, as amended (&#8220;</font><b style="font-size:12pt;font-weight:bold;">ERISA</b><font style="font-size:12pt;">&#8221;), for which the Company or any member of its &#8220;Controlled Group&#8221; (defined as any entity, whether or not incorporated, that is under common control with the Company within the meaning of Section&#160;4001(a)(14) of ERISA or any entity that would be regarded as a single employer with the Company under Section&#160;414(b),(c),(m) or (o) of the Code) would have any liability (each, a &#8220;</font><b style="font-size:12pt;font-weight:bold;">Plan</b><font style="font-size:12pt;">&#8221;) has been maintained in compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to ERISA and the Code; (ii) no prohibited transaction, within the meaning of Section&#160;406 of ERISA or Section&#160;4975 of the Code, has occurred with respect to any Plan, excluding transactions effected pursuant to a statutory or administrative exemption; (iii) for each Plan that is subject to the funding rules of Section&#160;412 of the Code or Section&#160;302 of ERISA, no Plan has failed (whether or not waived), or is reasonably expected to fail, to satisfy the minimum funding standards (within the meaning of Section&#160;302 of ERISA or Section&#160;412 of the Code) applicable to such Plan; (iv) no Plan is, or is reasonably expected to be, in &#8220;at risk status&#8221; (within the meaning of Section&#160;303(i) of ERISA) and no Plan that is a &#8220;multiemployer plan&#8221; within the meaning of Section&#160;4001(a)(3) of ERISA is in &#8220;endangered status&#8221; or &#8220;critical status&#8221; (within the meaning of Sections&#160;304 and 305 of ERISA) (v) the fair market value of the assets of each Plan exceeds the present value of all benefits accrued under such Plan (determined based on those assumptions used to fund such Plan); (vi) no &#8220;reportable event&#8221; (within the meaning of Section&#160;4043(c) of ERISA and the regulations promulgated thereunder) has occurred or is reasonably expected to occur; (vii) each Plan that is intended to be qualified under Section&#160;401(a) of the Code is so qualified, and nothing has occurred, whether by action or by failure to act, which would cause the loss of such qualification; (viii) neither the Company nor any member of the Controlled Group has incurred, nor reasonably expects to incur, any liability under Title IV of ERISA (other than contributions to the Plan or premiums to the Pension Benefit Guaranty Corporation, in the ordinary course and without default) in respect of a Plan (including a &#8220;multiemployer plan&#8221; within the meaning of Section&#160;4001(a)(3) of ERISA); and (ix) none of the following events has occurred or is</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">16</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">reasonably likely to occur: (A) a material increase in the aggregate amount of contributions required to be made to all Plans by the Company or its Controlled Group affiliates in the current fiscal year of the Company and its Controlled Group affiliates compared to the amount of such contributions made in the Company&#8217;s and its Controlled Group affiliates&#8217; most recently completed fiscal year; or (B) a material increase in the Company and its subsidiaries&#8217; &#8220;accumulated post-retirement benefit obligations&#8221; (within the meaning of Accounting Standards Codification Topic 715-60) compared to the amount of such obligations in the Company and its subsidiaries&#8217; most recently completed fiscal year, except in each case with respect to the events or conditions set forth in (i) through (ix) hereof, as would not, individually or in the aggregate, have a Material Adverse Effect.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(aa)</font></font><font style="font-size:12pt;">Except as disclosed in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus, the Company and its subsidiaries maintain an effective system of &#8220;disclosure controls and procedures&#8221; (as defined in Rule 13a-15(e) of the Exchange Act) that complies with the requirements of the Exchange Act and that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission&#8217;s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company&#8217;s management as appropriate to allow timely decisions regarding required disclosure. The Company and its subsidiaries have carried out evaluations of the effectiveness of their disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(bb)</font></font><font style="font-size:12pt;">Except as disclosed in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus, the Company and its subsidiaries maintain systems of &#8220;internal control over financial reporting&#8221; (as defined in Rule 13a-15(f) of the Exchange Act) that comply with the requirements of the Exchange Act and have been designed by, or under the supervision of, their respective principal executive and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. Except as disclosed in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus, the Company and its subsidiaries maintain internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management&#8217;s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management&#8217;s general or specific authorization; (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences and (v) interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus fairly presents the information called for in all material respects and is prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto based on the Company&#8217;s most recent evaluation of its internal controls over financial reporting pursuant to Rule 13a-15(c) of the Exchange Act. Except as disclosed in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus, there are no material weaknesses in the Company&#8217;s internal controls. The Company&#8217;s auditors and the Audit Committee of the Board of Directors of the Company have been advised of: (i) all significant deficiencies and material weaknesses in the</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">17</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">design or operation of internal controls over financial reporting which have adversely affected or are reasonably likely to adversely affect the Company&#8217;s ability to record, process, summarize and report financial information; and (ii) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&#8217;s internal controls over financial reporting. The Registration Statement and the documents incorporated by reference contain all XBRL Data required to be included therein; and the XBRL Data included or incorporated by reference in the Registration Statement or the documents incorporated by reference therein fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(cc)</font></font><font style="font-size:12pt;">The Company and its subsidiaries, taken as a whole, have insurance in such amounts and covering such risks as are, in the reasonable judgment of the Company, adequate to protect the Company and its subsidiaries and their respective businesses and properties; and neither the Company nor any of its subsidiaries has (i) received notice from any insurer or agents of such insurer that capital improvements or other expenditures are required or necessary to be made in order to continue such insurance or (ii) any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage at reasonable cost from similar insurers as may be necessary to continue its business.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(dd)</font></font><font style="font-size:12pt;">The operations of the Company and its subsidiaries are and have been conducted at all times in material compliance with applicable financial recordkeeping and reporting requirements, including those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the applicable money laundering statutes of all jurisdictions where the Company or any of its subsidiaries conducts business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &#8220;Anti-Money Laundering Laws&#8221;), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(ee)</font></font><font style="font-size:12pt;">The information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications, and databases owned or used by the Company or its subsidiaries (collectively, &#8220;IT Systems&#8221;) are reasonably adequate for, and operate and perform in all material respects as required in connection with the operation of the business of the Company and its subsidiaries as currently conducted, and, to the knowledge of the Company, are free and clear of all bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants that would cause a material disruption to the operation of the business of the Company and its subsidiaries. The Company and its subsidiaries have implemented and maintain commercially reasonable controls, policies, procedures, and safeguards designed to maintain and protect the secrecy of their material confidential information and the integrity, continuous operation, redundancy and security of IT Systems and data in the Company&#8217;s possession or control (including all personal, personally identifiable, sensitive, confidential or regulated data (&#8220;Personal Data&#8221;)) collected, used, stored or processed in connection with their businesses, and, to the knowledge of the Company, there have been no breaches, violations, outages or unauthorized uses of or accesses to same, in each case, except as have not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, nor any incidents under internal review or investigations relating to the same. The Company and its</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">18</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification, in each case, except as have not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(ff)</font></font><font style="font-size:12pt;">Neither the Company nor any of its subsidiaries, nor any director, officer or employee of the Company or any of its subsidiaries nor, to the knowledge of the Company, any agents, affiliate or other person acting on behalf of the Company or any of its subsidiaries has violated or is in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended, or any applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offence under the U.K. Bribery Act 2010 of the United Kingdom or any other applicable anti-bribery or anti-corruption law (collectively, the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Anti-Corruption Laws</b><font style="font-size:12pt;">&#8221;), nor have any of the foregoing: (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii) made or taken an act in furtherance of an offer, promise or authorization of any direct or indirect unlawful payment or benefit to any foreign or domestic government official or employee, including of any government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office; or (iii) made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other unlawful or improper payment or benefit. The Company and its subsidiaries have instituted, maintain and enforce, and will continue to maintain and enforce, policies and procedures reasonably designed to promote and ensure compliance with all applicable Anti-Corruption Laws.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(gg)</font></font><font style="font-size:12pt;">Neither the Company nor any of its subsidiaries, directors, officers or employees, nor, to the knowledge of the Company, any agents, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries is currently the subject or the target of any sanctions administered or enforced by the U.S.&#160;government, (including, without limitation, the Office of Foreign Assets Control of the U.S.&#160;Department of the Treasury or the U.S.&#160;Department of State and including, without limitation, the designation as a &#8220;specially designated national&#8221; or &#8220;</font><b style="font-size:12pt;font-weight:bold;">blocked person</b><font style="font-size:12pt;">&#8221;), the United Nations Security Council, the European Union, His Majesty&#8217;s Treasury or other relevant sanctions authority (collectively, &#8220;</font><b style="font-size:12pt;font-weight:bold;">Sanctions</b><font style="font-size:12pt;">&#8221;), nor is the Company or any of its subsidiaries operating, organized or resident in a country or territory that is the subject or target of Sanctions, including, without limitation, Cuba, Iran, North Korea, Syria the Crimea Region of Ukraine, the so-called Donetsk People&#8217;s Republic, the so-called Luhansk People&#8217;s Republic and any other covered region of Ukraine identified pursuant to Executive Order 14065 (each, a &#8220;</font><b style="font-size:12pt;font-weight:bold;">Sanctioned Country</b><font style="font-size:12pt;">&#8221;). For the past five years, the Company and its subsidiaries have not engaged in and are not now engaged in any dealings or transactions with any person that at the time of the dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Country.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(hh)</font></font><font style="font-size:12pt;">No subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, from paying any dividends</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">19</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">to the Company, from making any other distribution on such subsidiary&#8217;s capital stock or similar ownership interest, from repaying to the Company any loans or advances to such subsidiary from the Company or from transferring any of such subsidiary&#8217;s properties or assets to the Company or any other subsidiary of the Company, except as described in or contemplated by the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(ii)</font></font><font style="font-size:12pt;">Neither the Company nor any of its subsidiaries is a party to any contract, agreement or understanding with any person (other than this Agreement or any Terms Agreement) that would give rise to a valid claim against any of them or the Agents for a brokerage commission, finder&#8217;s fee or like payment in connection with the offering and sale of the Shares.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(jj)</font></font><font style="font-size:12pt;">Neither the Company nor any subsidiary or affiliate of the Company has taken nor will the Company or any subsidiary or affiliate of the Company take, directly or indirectly, any action which is designed to or which has constituted or which would reasonably be expected to cause or result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Shares.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(kk)</font></font><font style="font-size:12pt;">Except as disclosed in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus, no person has the right to require the Company or any of its subsidiaries to register any securities for sale under the Act by reason of the filing of the Registration Statement with the Commission or, to the knowledge of the Company, the issuance and sale of the Shares, except for such rights as have been duly waived.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(ll)</font></font><font style="font-size:12pt;">The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(mm)</font></font><font style="font-size:12pt;">No forward-looking statement (within the meaning of Section 27A of the Act and Section 21E of the Exchange Act) contained or incorporated by reference in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(nn)</font></font><font style="font-size:12pt;">Nothing has come to the attention of the Company that has caused the Company to believe that the statistical and market-related data included in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus is not based on or derived from sources that are reliable and accurate in all material respects.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">(oo)</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(pp)</font></font><font style="font-size:12pt;">There is and has been no failure on the part of the Company or any of the Company&#8217;s directors or officers, in their capacities as such, to comply with any provision of the Sarbanes-Oxley Act of 2002, as amended and the rules and regulations promulgated in connection therewith (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Sarbanes-Oxley Act</b><font style="font-size:12pt;">&#8221;), as applicable, including Section&#160;402 related to loans and Sections&#160;302 and 906 related to certifications as applicable.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">20</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(qq)</font></font><font style="font-size:12pt;">All of the Shares that have been or may be sold under this Agreement and any Terms Agreement have been approved for listing, subject only to official notice of issuance, on the Exchange.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(rr)</font></font><font style="font-size:12pt;">The Common Stock is an &#8220;actively-traded security&#8221; excepted from the requirements of Rule 101 of Regulation M under the Exchange Act by Rule 101 (c)(1) thereunder.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(ss)</font></font><font style="font-size:12pt;">Any certificate signed by any officer, general partner, managing member or other authorized representative of the Company or any subsidiary of the Company and delivered to the Agents or to counsel to the Agents pursuant to or in connection with this Agreement or any Terms Agreement shall be deemed a representation and warranty by the Company to the Agents as to the matters covered thereby.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(tt)</font></font><font style="font-size:12pt;">The Company will not directly or indirectly use the proceeds of the offering of the Shares hereunder, or lend, contribute or otherwise make available such proceeds to a subsidiary, joint venture partner or other person or entity (i) to fund or facilitate any activities of or business with any person that, at the time of such funding or facilitation, is the subject of target of Sanctions, (ii) to fund or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner that will result in a violation by any person (including any person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of Sanctions.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:14.4pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:21.6pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">4.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Certain Covenants of the Company.</u><font style="font-size:12pt;"> The Company hereby agrees with the Agents:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(a)</font></font><font style="font-size:12pt;">For so long as the delivery of a prospectus is required (whether physically or through compliance with Rule 172 under the Act or any similar rule) in connection with the offering or sale of Shares, before using or filing any Permitted Free Writing Prospectus and before using or filing any amendment or supplement to the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus (in each case, other than due to the filing of an Incorporated Document), to furnish to the Agents a copy of each such proposed Permitted Free Writing Prospectus, amendment or supplement within a reasonable period of time before filing with the Commission or using any such Permitted Free Writing Prospectus, amendment or supplement and the Company will not use or file any such Permitted Free Writing Prospectus or any such proposed amendment or supplement to which the Agents reasonably objects, unless the Company&#8217;s legal counsel has advised the Company that use or filing of such document is required by law; and the Company will not use or file any such Permitted Free Writing Prospectus or proposed, amendment or supplement to which the Agents reasonably objects unless the Company&#8217;s legal counsel has advised the Company that use or filing of such document is required by law.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(b)</font></font><font style="font-size:12pt;">To file the Prospectus, each Prospectus Supplement and any other amendments or supplements to the Prospectus pursuant to, and within the time period required by, Rule 424(b) under the Act (without reference to Rule 424(b)(8)) and to file any Permitted Free Writing Prospectus to the extent required by Rule 433 under the Act and to provide copies of the Prospectus, each Prospectus Supplement, any other amendments or supplements to the Prospectus and each Permitted Free Writing Prospectus (to the extent not previously delivered or</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">21</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">filed on the Commission&#8217;s Electronic Data Gathering, Analysis and Retrieval system or any successor system thereto (collectively, &#8220;</font><b style="font-size:12pt;font-weight:bold;">EDGAR</b><font style="font-size:12pt;">&#8221;)) to the Agents&#8217; via e-mail in &#8220;.pdf&#8221; format on such filing date to an e-mail account designated by the Agents and, at the Agents&#8217;s request, to also furnish copies of the Prospectus, each Prospectus Supplement, any other amendments or supplements to the Prospectus and each Permitted Free Writing Prospectus to each exchange or market on which sales were effected as may be required by the rules or regulations of such exchange or market.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(c)</font></font><font style="font-size:12pt;">To file timely all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act for so long as the delivery of a prospectus is required (whether physically or through compliance with Rule 172 under the Act or any similar rule) in connection with the offering or sale of the Shares, and during such same period to advise the Agents, promptly after the Company receives notice thereof, (i) of the time when any amendment to the Registration Statement has been filed or has become effective or any supplement to the Prospectus or any Permitted Free Writing Prospectus or any amended Prospectus has been filed with the Commission; (ii)&#160;of the issuance by the Commission of any stop order or any order preventing or suspending the use of any prospectus relating to the Shares or the initiation or threatening of any proceeding for that purpose, pursuant to Section 8A of the Act; (iii)&#160;of any objection by the Commission to the use of Form S-3ASR by the Company pursuant to Rule&#160;401(g)(2) under the Act; (iv) of the suspension of the qualification of the Shares for offering or sale in any jurisdiction or of the initiation or threatening of any proceeding for any such purpose; (v) of any request by the Commission for the amendment of the Registration Statement or the amendment or supplementation of the Prospectus (in each case including any documents incorporated by reference therein) or for additional information; (vi) of the occurrence of any event as a result of which the Prospectus or any Permitted Free Writing Prospectus as then amended or supplemented includes any untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus or any such Permitted Free Writing Prospectus is delivered to a purchaser, not misleading; and (vii) of the receipt by the Company of any notice of objection of the Commission to the use of the Registration Statement or any post-effective amendment thereto.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(d)</font></font><font style="font-size:12pt;">In the event of the issuance of any such stop order or of any such order preventing or suspending the use of any such prospectus or suspending any such qualification, or of any notice of objection pursuant to Rule&#160;401(g)(2) under the Act, to use promptly its commercially reasonable efforts to obtain its withdrawal.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(e)</font></font><font style="font-size:12pt;">To furnish such information as may be required and otherwise cooperate in qualifying the Shares for offering and sale under the securities or blue sky laws of such states or other jurisdictions as the Agents may reasonably designate and to maintain such qualifications in effect so long as required for the distribution of the Shares; provided that the Company shall not be required to qualify as a foreign corporation, become a dealer of securities, or become subject to taxation in, or to consent to the service of process under the laws of, any such state or other jurisdictions (except service of process with respect to the offering and sale of the Shares); and to promptly advise the Agents of the receipt by the Company of any notification with respect to the</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">22</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">suspension of the qualification of the Shares for sale in any jurisdiction or the initiation of any proceeding for such purpose.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(f)</font></font><font style="font-size:12pt;">To make available to the Agents at their offices in New York City, without charge, as soon as reasonably practicable after the Registration Statement becomes effective, and thereafter from time to time to furnish to the Agents, as many copies of the Prospectus and the Prospectus Supplement (or of the Prospectus or Prospectus Supplement as amended or supplemented if the Company shall have made any amendments or supplements thereto and documents incorporated by reference therein after the effective date of the Registration Statement) and each Permitted Free Writing Prospectus as the Agents may reasonably request for so long as the delivery of a prospectus is required (whether physically or through compliance with Rule 172 under the Act or any similar rule); and for so long as this Agreement is in effect, the Company will prepare and file promptly such amendment or amendments to the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus as may be necessary to comply with the requirements of Section 10(a)(3) of the Act.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(g)</font></font><font style="font-size:12pt;">To furnish or make available to the Agents during the Term (i) copies of any reports or other communications which the Company shall send to its shareholders or shall from time to time publish or publicly disseminate and (ii) copies of all annual, quarterly and current reports filed with the Commission on Forms 10-K, 10-Q and 8-K, or such other similar form as may be designated by the Commission, and to furnish to the Agents from time to time during the Term such other information as the Agents may reasonably request regarding the Company or its subsidiaries, in each case as soon as such reports, communications, documents or information becomes available or promptly upon the request of the Agents, as applicable; provided, however, that the Company shall have no obligation to provide the Agents with any document filed on EDGAR or included on the Company&#8217;s Internet website.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(h)</font></font><font style="font-size:12pt;">If, at any time during the Term, any event shall occur or condition shall exist as a result of which it is necessary in the reasonable opinion of counsel for the Agents or counsel for the Company, to further amend or supplement the Prospectus or any Permitted Free Writing Prospectus as then amended or supplemented in order that the Prospectus or any such Permitted Free Writing Prospectus will not include an untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein not misleading, in light of the circumstances existing at the time the Prospectus or any such Permitted Free Writing Prospectus is delivered to a purchaser, or if it shall be necessary, in the reasonable opinion of either such counsel, to amend or supplement the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus in order to comply with the requirements of the Act, in the case of such a determination by counsel to the Company, immediate notice shall be given, and confirmed in writing, to the Agents to cease the solicitation of offers to purchase the Shares in the Agents&#8217; capacity as Agents, and, in either case, the Company will, subject to Section 4(a) above, promptly prepare and file with the Commission such amendment or supplement, whether by filing documents pursuant to the Act, the Exchange Act or otherwise, as may be necessary to correct such untrue statement or omission or to make the Registration Statement, the Prospectus or any such Permitted Free Writing Prospectus comply with such requirements.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">23</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(i)</font></font><font style="font-size:12pt;">To generally make available to its security holders as soon as reasonably practicable, but not later than 16 months after the first day of each fiscal quarter referred to below, an earnings statement (in form complying with the provisions of Section 11(a) under the Act and Rule 158 of the Commission promulgated thereunder) covering each twelve-month period beginning, in each case, not later than the first day of the Company&#8217;s fiscal quarter next following each &#8220;effective date&#8221; (as defined in such Rule 158) of the Registration Statement with respect to each sale of Shares.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(j)</font></font><font style="font-size:12pt;">To apply the net proceeds from the sale of the Shares in the manner described in the Prospectus Supplement under the caption &#8220;Use of Proceeds.&#8221;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(k)</font></font><font style="font-size:12pt;">Not to, and to cause its subsidiaries not to, take, directly or indirectly, any action designed to cause or result in, or that constitutes or might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Shares; </font><i style="font-size:12pt;font-style:italic;">provided</i><font style="font-size:12pt;"> that nothing herein shall prevent the Company from filing or submitting reports under the Exchange Act or issuing press releases in the ordinary course of business.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(l)</font></font><font style="font-size:12pt;">Except as otherwise agreed between the Company and the Agents, to pay all costs, expenses, fees and taxes in connection with (i) the preparation and filing of the Registration Statement, the Prospectus, any Permitted Free Writing Prospectus, and any amendments or supplements thereto, and the printing and furnishing of copies of each thereof to the Agents and to dealers (including costs of mailing and shipment), (ii) the registration, issue and delivery of the Shares, (iii) the qualification of the Shares for offering and sale under the securities or blue sky laws of such states or other jurisdictions as the Agents may reasonably designate as aforesaid (including filing fees and the reasonable legal fees and disbursements of counsel to the Agents in connection therewith) and the printing and furnishing of copies of any blue sky surveys to the Agents, (iv)&#160;the listing of the Shares on the Exchange and any registration thereof under the Exchange Act, (v) any filing for review, and any review, of the public offering of the Shares by FINRA (including reasonable filing fees and the legal fees and disbursements of counsel to the Agents in connection therewith), (vi) the fees and disbursements of counsel to the Company and of the Company&#8217;s independent registered public accounting firm and (vii) the performance of the Company&#8217;s other obligations hereunder and under any Terms Agreement. If Shares having an aggregate offering price of at least $75,000,000 have not been offered and sold under this Agreement and all Terms Agreements by the Agents prior to November 10, 2025 (or such earlier date on which the Company terminates this Agreement), the Company shall reimburse the Agents for up to $150,000 of its reasonable, documented out-of-pocket expenses, including the reasonable fees and disbursements of counsel for the Agents, incurred by it in connection with the offering contemplated by this Agreement, including, without limitation, the preparation and negotiation of this Agreement, the original closing with respect to this Agreement and the periodic delivery of documents hereunder.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(m)</font></font><font style="font-size:12pt;">With respect to the offering(s) contemplated by this Agreement or any Terms Agreement, the Company will not offer shares of Common Stock or any securities convertible into or exchangeable or exercisable for shares of the Common Stock in a manner in violation of the Act or the Exchange Act; and the Company will not distribute any offering material in connection with the offer and sale of the Shares, other than the Registration Statement, the</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">24</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">Prospectus or any Permitted Free Writing Prospectus and any amendments or supplements thereto.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(n)</font></font><font style="font-size:12pt;"> Unless the Company has given written notice to the Agents that the Company has suspended activity under this Agreement and there are no pending Agency Transactions or Principal Transactions, the Company will not, without (A)&#160;giving the Agents at least three Exchange Business Days&#8217; prior written notice specifying the nature of the proposed sale and the date of such proposed sale and (B)&#160;the Agents suspending activity under this program for such period of time as requested by the Company or deemed appropriate by the Agents in light of the proposed sale, (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or other equity securities of the Company or any securities convertible into or exercisable, redeemable or exchangeable for Common Stock or other equity securities of the Company, or submit to, or file with, the Commission any registration statement under the Act with respect to any of the foregoing (other than a registration statement on Form S-8 or post-effective amendment to the Registration Statement), or publicly announce the intention to undertake any of the foregoing, or (ii) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of Common Stock or other equity securities of the Company, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of shares of Common Stock or other securities, in cash or otherwise. The foregoing sentence shall not apply to (A)&#160;Shares offered and sold under this Agreement or any Terms Agreement, (B) securities issued pursuant to any of the Company&#8217;s equity incentive plans described in the Registration Statement and the Prospectus or upon the exercise of options granted thereunder or (C) the issuance of shares of Common Stock issuable upon the exercise of convertible securities outstanding on the date hereof. Any lock-up provisions relating to a Principal Transaction shall be set forth in the applicable Terms Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(o)</font></font><font style="font-size:12pt;">The Company will, pursuant to reasonable procedures developed in good faith, retain copies of each Permitted Free Writing Prospectus that is not filed with the Commission in accordance with Rule 433 under the Act.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(p)</font></font><font style="font-size:12pt;">The Company will use commercially reasonable efforts to cause the Shares to be listed on the Exchange.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(q)</font></font><font style="font-size:12pt;">The Company consents to the Agents trading in the Common Stock for the Agents&#8217;s own account and for the account of its clients at the same time as sales of the Shares occur pursuant to this Agreement or any Terms Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(r)</font></font><font style="font-size:12pt;">If immediately prior to the third anniversary (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Renewal Deadline</b><font style="font-size:12pt;">&#8221;) of the initial effective date of the Registration Statement, the aggregate Gross Sales Price of Shares sold by the Company is less than the Maximum Amount and this Agreement has not expired or been terminated, the Company will, prior to the Renewal Deadline, file, if it has not already done so and is eligible to do so, a new automatic shelf registration statement relating to the Shares, in a form satisfactory to the Agents. If the Company is not eligible to file an automatic shelf registration statement, the Company will, prior to the Renewal Deadline, if it has not already done so, file a new shelf registration statement relating to the Shares, in a form satisfactory to the</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">25</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">Agents, and will use its best efforts to cause such registration statement to be declared effective within 180 days after the Renewal Deadline. The Company will take all other action necessary or appropriate to permit the issuance and sale of the Shares to continue as contemplated in the expired registration statement relating to the Shares. References herein to the Registration Statement shall include such new automatic shelf registration statement or such new shelf registration statement, as the case may be.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:18pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">5.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Execution of Agreement</u><font style="font-size:12pt;white-space:pre-wrap;">.  The Agents&#8217; obligations under this Agreement shall be subject to the satisfaction of the following conditions in connection with and on the date of the execution of this Agreement:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(a)</font></font><font style="font-size:12pt;">the Company shall have delivered to the Agents:</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(i)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">an officers</font><font style="font-family:'(normal text)';font-size:12pt;">&#8217;</font><font style="font-size:12pt;"> certificate signed by two officers of the Company (one of whom shall be the Chief Financial Officer or other senior financial officer) certifying as to the matters set forth in Exhibit B hereto;</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(ii)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">a letter or letters, which shall include legal opinions and negative assurance statements, of Vinson &amp; Elkins L.L.P., counsel for the Company, addressed to the Agents and dated the date of this Agreement, in the form of Exhibit C hereto;</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(iii)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">a </font><font style="font-family:'(normal text)';font-size:12pt;">&#8220;</font><font style="font-size:12pt;">comfort</font><font style="font-family:'(normal text)';font-size:12pt;">&#8221;</font><font style="font-size:12pt;"> letter from KPMG LLP, addressed to the Agents and dated the date of this Agreement, addressing such matters as the Agents may reasonably request;</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(iv)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">evidence reasonably satisfactory to the Agents and its counsel that the Shares have been approved for listing on the Exchange, subject only to notice of issuance on or before the date hereof; and</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(v)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">such other documents as the Agents shall reasonably request;</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(b)</font></font><font style="font-size:12pt;">The Agents shall have received a letter or letters, which shall include legal opinions and negative assurance statements, of Latham &amp; Watkins LLP, counsel to the Agents, addressed to the Agents and dated the date of this Agreement, addressing such matters as the Agents may reasonably request.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:18pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">6.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Additional Covenants of the Company</u><font style="font-size:12pt;white-space:pre-wrap;">.  The Company further covenants and agrees with the Agents as follows:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(a)</font></font><font style="font-size:12pt;">Each Transaction Proposal made by the Company that is accepted by the Agents by means of a Transaction Acceptance and each execution and delivery by the Company of a Terms Agreement shall be deemed to be (i) an affirmation that the representations, warranties and agreements of the Company herein contained and contained in any certificate delivered to the Agents pursuant hereto are true and correct at such Time of Acceptance or the date of such Terms Agreement, as the case may be, and (ii) an undertaking that such representations, warranties and agreements will be true and correct on any applicable Time of Sale and Settlement Date, as though made at and as of each such time (it being understood that such</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">26</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">representations, warranties and agreements shall relate to the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus as amended and supplemented to the time of such Transaction Acceptance or Terms Agreement, as the case may be).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(b)</font></font><font style="font-size:12pt;">Each time that (i) the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus shall be amended or supplemented (including, except as noted in the proviso at the end of this Section 6(b), by the filing of any Incorporated Document), (ii) there is a Principal Settlement Date pursuant to a Terms Agreement, or (iii) the Agents shall reasonably request (each date referred to clauses (i), (ii) and (iii) above, a &#8220;</font><b style="font-size:12pt;font-weight:bold;">Bring-Down Delivery Date</b><font style="font-size:12pt;">&#8221;), the Company shall, unless the Agents agree otherwise, furnish or cause to be furnished to the Agents certificates, dated as of such Bring-Down Delivery Date and delivered within three Exchange Business Days after the applicable Bring-Down Delivery Date or, in the case of a Bring-Down Delivery Date resulting from a Principal Settlement Date, delivered on such Principal Settlement Date, of the same tenor as the certificates referred to in Sections 5(a)(i) and 5(a)(iv) hereof, modified as necessary to relate to the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus as amended and supplemented to the time of delivery of such certificates, or, in lieu of such certificates, certificates to the effect that the statements contained in the certificates referred to in Sections 5(a)(i) hereof furnished to the Agents are true and correct as of such Bring-Down Delivery Date as though made at and as of such date (except that such statements shall be deemed to relate to the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus as amended and supplemented to the time of delivery of such certificate); </font><i style="font-size:12pt;font-style:italic;">provided</i><font style="font-size:12pt;">, </font><i style="font-size:12pt;font-style:italic;">however</i><font style="font-size:12pt;">, that the filing of a Current Report on Form 8-K will not constitute a Bring-Down Delivery Date under clause (i) above unless either (A) (x) such Current Report on Form 8-K is filed at any time during which either a Transaction Acceptance is binding and the Company has not suspended the use thereof (and prior to the settlement of the Shares specified therein) or a prospectus relating to the Shares is required to be delivered under the Act (whether physically or through compliance with Rule 172 under the Act or any similar rule) or such Current Report on Form 8-K is filed at any time from and including the date of a Terms Agreement through and including the related Settlement Date and (y) the Agents have reasonably requested that such date be deemed to be a Bring-Down Delivery Date based upon the event or events reported in such Current Report on Form 8-K or (B) such Current Report on Form 8-K contains capsule financial information, historical or pro forma financial statements, supporting schedules or other financial data, including any Current Report on Form 8-K or part thereof under Item 2.02 of Regulation S-K of the Commission that is considered &#8220;filed&#8221; under the Exchange Act; and </font><i style="font-size:12pt;font-style:italic;">provided, further,</i><font style="font-size:12pt;"> that an amendment or supplement to the Registration Statement or the Prospectus solely relating to the offering of other securities pursuant to the Registration Statement will not constitute a Bring-Down Delivery Date.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(c)</font></font><font style="font-size:12pt;">Each Bring-Down Delivery Date, the Company shall, unless the Agents agrees otherwise, cause to be furnished to Agents (A) a letter or letters, which shall include legal opinions and negative assurance statements of Vinson &amp; Elkins L.L.P., counsel to the Company, and a letter or letters, which shall include legal opinions and negative assurance statements of Latham &amp; Watkins LLP, counsel to the Agents, each dated as of the applicable Bring-Down Delivery Date and delivered within three Exchange Business Days after the applicable Bring-Down Delivery Date or, in the case of a Bring-Down Delivery Date resulting from a Principal Settlement Date, dated and delivered on such Principal Settlement Date, of the same tenor as the letters referred to in Section 5(a)(ii) or Section 5(b) hereof, as applicable, but modified as</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">27</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">necessary to relate to the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus as amended and supplemented to the time of delivery of such letters, or, in lieu of such letters, such counsel shall furnish the Agents with a letter substantially to the effect that the Agents may rely on the letters of such counsel referred to in Section 5(a)(ii) or Section 5(b), as applicable, furnished to the Agents, to the same extent as though they were dated the date of such letter authorizing reliance (except that statements in such last letters of such counsel shall be deemed to relate to the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus as amended and supplemented to the time of delivery of such letters authorizing reliance).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(d)</font></font><font style="font-size:12pt;">Each Bring-Down Delivery Date, the Company shall, unless the Agents agrees otherwise, cause KPMG LLP to furnish to the Agents a &#8220;comfort&#8221; letter, dated as of the applicable Bring-Down Delivery Date and delivered within three Exchange Business Days after the applicable Bring-Down Delivery Date or, in the case of a Bring-Down Delivery Date resulting from a Principal Settlement Date, delivered on such Principal Settlement Date, of the same tenor as the letter referred to in Section 5(a)(iii) hereof, but modified to relate to the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus as amended and supplemented to the date of such letter, and, if the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus shall include or incorporate by reference the financial statements of any entity or business (other than the consolidated financial statements of the Company and its subsidiaries), the Company shall, if requested by the Agents, cause a firm of independent public accountants to furnish to the Agents a &#8220;comfort&#8221; letter, dated as of the applicable Bring-Down Delivery Date and delivered within three Exchange Business Days after the applicable Bring-Down Delivery Date or, in the case of a Bring-Down Delivery Date resulting from a Principal Settlement Date, delivered on such Principal Settlement Date, addressing such matters as the Agents may reasonably request</font><b style="font-size:12pt;font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(e)</font></font><font style="font-size:12pt;">(i) No order suspending the effectiveness of the Registration Statement shall be in effect, and no proceeding for such purpose or pursuant to Section 8A under the Act shall be pending before or threatened by the Commission; the Prospectus and each Permitted Free Writing Prospectus shall have been timely filed with the Commission under the Act (in the case of a Permitted Free Writing Prospectus, to the extent required by Rule 433 under the Act); and all requests by the Commission for additional information shall have been complied with to the satisfaction of the Agents and no suspension of the qualification of the Shares for offering or sale in any jurisdiction, or of the initiation or threatening of any proceedings for any of such purposes, shall have occurred and be in effect at the time the Company delivers a Transaction Proposal to the Agents or the time the Agents delivers a Transaction Acceptance to the Company; and (ii) the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus shall not contain an untrue statement of material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading at the time the Company delivers a Transaction Proposal to the Agents or the time the Agents delivers a Transaction Acceptance to the Company.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(f)</font></font><font style="font-size:12pt;">The Company shall reasonably cooperate with any reasonable due diligence review requested by the Agents or its counsel from time to time in connection with the transactions contemplated hereby or any Terms Agreement, including, without limitation, (i) at</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">28</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">the commencement of each intended Sale Date and any Time of Sale or Settlement Date, providing information and making available appropriate documents and appropriate corporate officers of the Company and, upon reasonable request, representatives of KPMG LLP (and, if the Registration Statement, the Prospectus or any Permitted Free-Writing Prospectus shall include or incorporate by reference the financial statements of any entity or business (other than the consolidated financial statements of the Company and its subsidiaries), representatives of the independent public accountants that audited or reviewed such financial statements) for an update on diligence matters with representatives of the Agents and (ii)&#160;at each Bring-Down Delivery Date and otherwise as the Agents may reasonably request, providing information and making available documents and appropriate corporate officers of the Company and representatives of KPMG LLP (and, if the Registration Statement, the Prospectus or any Permitted Free-Writing Prospectus shall include or incorporate by reference the financial statements of any entity or business (other than the consolidated financial statements of the Company and its subsidiaries), representatives of the independent public accountants that audited or reviewed such financial statements) for one or more due diligence sessions with representatives of the Agents and its counsel.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(g)</font></font><font style="font-size:12pt;">The Company shall disclose, in its quarterly reports on Form 10-Q and in its annual report on Form 10-K and, if requested by the Agents, in supplements to the Prospectus to be filed by the Company with the Commission from time to time, the number of the Shares sold through the Agents under this Agreement and any Terms Agreement, and the gross and net proceeds to the Company from the sale of the Shares and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter or, in the case of any such prospectus supplement, such shorter period as the Agents may reasonably request or, in the case of an Annual Report on Form 10-K, during the fiscal year covered by such Annual Report and the fourth quarter of such fiscal year.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">All opinions, letters and other documents referred to in Sections 6(b) through (d) above shall be reasonably satisfactory in form and substance to the Agents. The Agents will provide the Company with such notice (which may be oral, and in such case, will be confirmed via e-mail as soon as reasonably practicable thereafter) as is reasonably practicable under the circumstances when requesting an opinion, letter or other document referred to in Sections 6(b) through (d) above.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:18pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">7.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Conditions of the Agents&#8217; Obligation</u><font style="font-size:12pt;white-space:pre-wrap;">.  The Agents&#8217; obligation to solicit purchases on an agency basis for the Shares or otherwise take any action pursuant to a Transaction Acceptance and to purchase the Shares pursuant to any Terms Agreement shall be subject to the satisfaction of the following conditions:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(a)</font></font><font style="font-size:12pt;">At the Time of Acceptance, at the time of the commencement of trading on the Exchange on the Sale Date(s) and at the relevant Time of Sale and Agency Settlement Date, or with respect to a Principal Transaction pursuant to a Terms Agreement, at the time of execution and delivery of the Terms Agreement by the Company and at the relevant Time of Sale and Principal Settlement Date:</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(i)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">The representations, warranties and agreements on the part of the Company herein contained or contained in any certificate of an officer or</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">29</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 108pt;"><font style="font-size:12pt;">officers, general partner, managing member or other authorized representative of the Company or any subsidiary of the Company delivered pursuant to the provisions hereof shall be true and correct in all respects.</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(ii)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">The Company shall have performed and observed its covenants and other obligations hereunder and/or under any Terms Agreement, as the case may be, in all material respects.</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(iii)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">In the case of an Agency Transaction, from the Time of Acceptance until the Agency Settlement Date, or, in the case of a Principal Transaction pursuant to a Terms Agreement, from the time of execution and delivery of the Terms Agreement by the Company until the Principal Settlement Date, trading in the Common Stock on the Exchange shall not have been suspended.</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(iv)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">From the date of this Agreement, no event or condition of a type described in Section 3(e) hereof shall have occurred or shall exist, which event or condition is not described in a Permitted Free Writing Prospectus (excluding any amendment or supplement thereto) or the Prospectus (excluding any amendment or supplement thereto) and the effect of which in the judgment of the Agents makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares on the applicable Settlement Date on the terms and in the manner contemplated by this Agreement, any Terms Agreement, any Permitted Free Writing Prospectus and the Prospectus.</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(v)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">Subsequent to the relevant Time of Acceptance or, in the case of a Principal Transaction, subsequent to execution of the applicable Terms Agreement, (A) no downgrading shall have occurred in the rating accorded any debt securities or preferred equity securities of or guaranteed by the Company or any of its subsidiaries by any &#8220;nationally recognized statistical rating organization&#8221;, as such term is defined by the Commission for purposes of Section 3(a)(62) of the Exchange Act and (B) no such organization shall have publicly announced that it has under surveillance or review, or has changed its outlook with respect to, its rating of any debt securities or preferred equity securities of or guaranteed by the Company or any of its subsidiaries (other than an announcement with positive implications of a possible upgrading) in each case that has not been described in any Permitted Free Writing Prospectus issued prior to any related Time of Sale.</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(vi)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">The Shares to be issued pursuant to the Transaction Acceptance or pursuant to a Terms Agreement, as applicable, shall have been approved for listing on the Exchange, subject only to notice of issuance.</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">30</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(vii)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(A) No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the relevant Settlement Date, prevent the issuance or sale of the Shares and (B) no injunction or order of any federal, state or foreign court shall have been issued that would, as of the relevant Settlement Date, prevent the issuance or sale of the Shares.</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(viii)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(A) No order suspending the effectiveness of the Registration Statement shall be in effect, no proceeding for such purpose or pursuant to Section 8A of the Act shall be pending before or threatened by the Commission and no notice of objection of the Commission to the use of the Registration Statement pursuant to Rule 401(g)(2) under the Act shall have been received by the Company; (B) the Prospectus and each Permitted Free Writing Prospectus shall have been timely filed with the Commission under the Act (in the case of any Permitted Free Writing Prospectus, to the extent required by Rule 433 under the Act); (C) all requests by the Commission for additional information shall have been complied with to the satisfaction of the Agents; and (D) no suspension of the qualification of the Shares for offering or sale in any jurisdiction, and no initiation or threatening of any proceedings for any of such purposes, shall have occurred and be in effect. The Registration Statement, or the Prospectus or any Permitted Free Writing Prospectus shall not contain an untrue statement of material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading at the time the Agents delivers a Transaction Acceptance to the Company or the Company and the Agents execute a Terms Agreement, as the case may be.</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(ix)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">No amendment or supplement to the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus shall have been filed to which the Agents shall have reasonably objected in writing.</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(b)</font></font><font style="font-size:12pt;">Within three Exchange Business Days after the applicable Bring-Down Delivery Date or, in the case of a Bring-Down Delivery Date resulting from a Principal Settlement Date, on such Principal Settlement Date, the Agents shall have received the officer&#8217;s certificates, letters of counsel and &#8220;comfort&#8221; letters and other documents provided for under Sections 6(b) through (d), inclusive. For purposes of clarity and without limitation to any other provision of this Section&#160;7 or elsewhere in this Agreement, the parties hereto agree that the Agents&#8217; obligations, if any, to solicit purchases of Shares on an agency basis or otherwise take any action pursuant to a Transaction Acceptance shall, unless otherwise agreed in writing by the Agents, be suspended during the period from and including a Bring-Down Delivery Date through and including the time that the Agents shall have received the documents described in the preceding sentence.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">31</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:14.4pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:21.6pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">8.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination</u><font style="font-size:12pt;">.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:72pt;text-indent:-72pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(a)</font></font><font style="font-size:12pt;">(i) </font><font style="display:inline-block;width:21.67pt;"></font><font style="font-size:12pt;">The Company may terminate this Agreement in its sole discretion at any time upon prior written notice to the Agents. Any such termination shall be without liability of any party to any other party, except that (A) with respect to any pending sale, the obligations of the Company, including in respect of compensation of the Agents, shall remain in full force and effect notwithstanding such termination; and (B) the provisions of Sections 3, 4 (except that if no Shares have been previously sold hereunder or under any Terms Agreement, only Section&#160;4(l)), 9, 13, 14 and 16 of this Agreement shall remain in full force and effect notwithstanding such termination.</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(ii)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">In the case of any sale by the Company pursuant to a Terms Agreement, the obligations of the Company pursuant to such Terms Agreement and this Agreement may not be terminated by the Company without the prior written consent of the Agent party thereto.</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:67.5pt;text-indent:-67.5pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(b)</font></font><font style="font-size:12pt;">(i) </font><font style="display:inline-block;width:17.17pt;"></font><font style="font-size:12pt;">The Agents may terminate this Agreement in its sole discretion at any time upon giving prior written notice to the Company. Any such termination shall be without liability of any party to any other party, except that the provisions of Sections 3, 4 (except that if no Shares have been previously sold hereunder or under any Terms Agreement, only Section 4(l)), 9, 13, 14 and 16 of this Agreement shall remain in full force and effect notwithstanding such termination.</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:31.5pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">(ii)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:12pt;">In the case of any purchase by the Agents pursuant to a Terms Agreement, the obligations of the Agents pursuant to such Terms Agreement shall be subject to termination by the Agents at any time prior to or at the Principal Settlement Date if (A) since the time of execution of the Terms Agreement or the respective dates as of which information is given in the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus, (i)</font><font style="font-family:'(normal text)';font-size:12pt;">&#160;</font><font style="font-size:12pt;">trading generally shall have been suspended or materially limited on or by any of the New York Stock Exchange, the Nasdaq, the Chicago Board Options Exchange, the Chicago Mercantile Exchange or the Chicago Board of Trade; (ii)</font><font style="font-family:'(normal text)';font-size:12pt;">&#160;</font><font style="font-size:12pt;">trading of any securities issued or guaranteed by the Company or any of its subsidiaries shall have been suspended on any exchange or in any over-the counter market, (iii) a general moratorium on commercial banking activities shall have been declared by federal or New York state authorities, (iv) there shall have occurred any outbreak or escalation of hostilities or any change in financial markets or any calamity or crisis, either within or outside the United States, that, solely in the case of events and conditions described in this clause (iv), in the Agents</font><font style="font-family:'(normal text)';font-size:12pt;">&#8217;</font><font style="font-size:12pt;"> judgment, is material and adverse and makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares on the terms and in the manner contemplated in the Prospectus or such Terms Agreement. If the Agents elects to terminate its obligations pursuant to this Section 8(b)(ii), the Company shall be notified promptly in writing.</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">32</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(c)</font></font><font style="font-size:12pt;">This Agreement shall remain in full force and effect until the earliest of (A)&#160;termination of this Agreement pursuant to Section 8(a) or 8(b) above or otherwise by mutual written agreement of the parties, (B) such date that the Maximum Amount of Shares has been sold in accordance with the terms of this Agreement and any Terms Agreements and (C) the third anniversary of the date of this Agreement, in each case except that the provisions of Section 3, 4 (except that if no Shares have been previously sold hereunder or under any Terms Agreement, only Section 4(l)), 9, 13, 14 and 16 of this Agreement shall remain in full force and effect notwithstanding such termination.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(d)</font></font><font style="font-size:12pt;">Any termination of this Agreement shall be effective on the date specified in such notice of termination; </font><i style="font-size:12pt;font-style:italic;">provided</i><font style="font-size:12pt;"> that, notwithstanding the foregoing, such termination shall not be effective until the close of business on the date of receipt of such notice by the Agents or the Company, as the case may be, or such later date as may be required pursuant to Section&#160;8(a) or (b). If such termination shall occur prior to the Settlement Date for any sale of Shares, such sale shall settle in accordance with the provisions of Section 2 hereof.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:14.4pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:21.6pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">9.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Indemnity and Contribution</u><font style="font-size:12pt;">.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(a)</font></font><font style="font-size:12pt;">The Company agrees to indemnify and hold harmless the Agents, its affiliates, directors and officers and each person, if any, who controls the Agents within the meaning of Section 15 of the Act or Section 20 of the Exchange Act, from and against any and all losses, claims, damages and liabilities (including, without limitation, reasonable out of pocket legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred), that arise out of, or are based upon, (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereto) or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary in order to make the statements therein, not misleading or (ii) any untrue statement or alleged untrue statement of a material fact contained in the Prospectus (or any amendment or supplement thereto), any Permitted Free Writing Prospectus (or any amendment or supplement thereto), any &#8220;issuer information&#8221; filed or required to be filed pursuant to Rule 433(d) under the Act or any road show as defined in Rule 433(h) under the Act (a &#8220;</font><b style="font-size:12pt;font-weight:bold;">road show</b><font style="font-size:12pt;">&#8221;), or caused by any omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, in each case except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to the Agents furnished to the Company in writing by the Agents expressly for use therein, it being understood and agreed that the only such information furnished by the Agents consists of the information described as such in subsection (b) below.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(b)</font></font><font style="font-size:12pt;">The Agents agrees to indemnify and hold harmless the Company, its directors, its officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section 15 of the Act or Section 20 of the Exchange Act to the same extent as the indemnity set forth in paragraph (a) above, but only with respect to any losses, claims, damages or liabilities that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to the Agents furnished to the Company in writing by the Agents</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">33</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">expressly for use in the Registration Statement (or any amendment thereto), the Prospectus (or any amendment or supplement thereto), any Permitted Free Writing Prospectus (or any amendment or supplement thereto) or any road show it being understood and agreed upon that such information shall consist solely of the name and contact information of the Agents in the Prospectus.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(c)</font></font><font style="font-size:12pt;">If any suit, action, proceeding (including any governmental or regulatory investigation), claim or demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to either Section&#160;9(a) or 9(b) above, such person (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Indemnified Person</b><font style="font-size:12pt;">&#8221;) shall promptly notify the person against whom such indemnification may be sought (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Indemnifying Person</b><font style="font-size:12pt;">&#8221;) in writing; </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u><font style="font-size:12pt;"> that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have under this Section&#160;9 except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u><font style="font-size:12pt;">, </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">further</u><font style="font-size:12pt;">, that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise than under this Section&#160;9. If any such proceeding shall be brought or asserted against an Indemnified Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying Person) to represent the Indemnified Person and any others entitled to indemnification pursuant to this Section 9 that the Indemnifying Person may designate in such proceeding and shall pay the fees and expenses of such counsel related to such proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (i) the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary; (ii)&#160;the Indemnifying Person has failed within a reasonable time to retain counsel reasonably satisfactory to the Indemnified Person; (iii)&#160;the Indemnified Person shall have reasonably concluded that there may be legal defenses available to it that are different from or in addition to those available to the Indemnifying Person; or (iv)&#160;the named parties in any such proceeding (including any impleaded parties) included both the Indemnifying Person and the Indemnified Person and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood and agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same jurisdiction, be liable for the reasonable fees and expenses of more than one separate firm (in addition to any local counsel) for (A)&#160;the Agents and its affiliates, directors and officers and its control persons, if any, or (B)&#160;the Company, its directors, its officers who signed the Registration Statement and its control persons, if any, as the case may be, and that all such reasonable fees and expenses shall be paid or reimbursed as they are incurred. Any such separate firm for the Agents and its affiliates, directors and officers and its control persons, if any, shall be designated in writing by the Agents, and any such separate firm for the Company, its directors, its officers who signed the Registration Statement and its control persons, if any, shall be designated in writing by the Company. The Indemnifying Person shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or liability by reason of such settlement or judgment. No Indemnifying Person shall, without the written consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">34</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">is or could have been a party and indemnification is or could have been sought hereunder by such Indemnified Person, unless such settlement (x) includes an unconditional release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from all liability on claims that are the subject matter of such proceeding and (y) does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person. Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall have requested an Indemnifying Person to reimburse the Indemnified Person for fees and expenses of counsel as contemplated by this Section 9(c), the Indemnifying Person agrees that it shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 30 days after receipt by such Indemnifying Person of the aforesaid request and (ii) such Indemnifying Person shall not have reimbursed the Indemnified Person in accordance with such request prior to the date of such settlement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(d)</font></font><font style="font-size:12pt;">If the indemnification provided for in Sections&#160;9(a) and 9(b) above is unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such Sections, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable by such Indemnified Person as a result of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the Company, on the one hand, and the Agents, on the other, from the offering of the Shares pursuant to this Agreement and any Terms Agreements or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) but also the relative fault of the Company, on the one hand, and the Agents, on the other, in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company, on the one hand, and the Agents, on the other, shall be deemed to be in the same respective proportions as the net proceeds (before deducting expenses) received by the Company from the sale of the Shares pursuant to this Agreement and any Terms Agreements and the total discounts and commissions received by the Agents in connection therewith bear to the aggregate Gross Sales Price of such Shares. The relative fault of the Company, on the one hand, and Agents, on the other, shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company, on the one hand, or by Agents, on the other hand, and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(e)</font></font><font style="font-size:12pt;">The Company and the Agents agree that it would not be just and equitable if contribution pursuant to this Section&#160;9 were determined by </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">pro rata</u><font style="font-size:12pt;"> allocation or by any other method of allocation that does not take account of the equitable considerations referred to in Section&#160;9(d) above. The amount paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in Section&#160;9(d) above shall be deemed to include, subject to the limitations set forth above, any legal or other expenses incurred by such Indemnified Person in connection with any such action or claim. Notwithstanding the provisions of this Section&#160;9, in no event shall the Agents be required to contribute any amount in excess of the amount by which the total discounts and commissions received by the Agents with respect to the offering of the Shares pursuant to this Agreement and any Terms Agreements exceeds the</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">35</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">amount of any damages that the Agents has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(f)</font></font><font style="font-size:12pt;">The remedies provided for in this Section&#160;9 are not exclusive and shall not limit any rights or remedies which may otherwise be available to any Indemnified Person at law or in equity.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:14.4pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:21.6pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">10.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notices</u><font style="font-size:12pt;white-space:pre-wrap;">.  All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted and confirmed by any standard form of telecommunication. Notices to the Underwriters shall be given to the Representatives c/o J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179 (fax: (212) 622-8358); Attention: Equity Syndicate Desk, c/o Evercore Group L.L.C., 55 East 52</font><sup style="font-size:9pt;vertical-align:top;">nd</sup><font style="font-size:12pt;"> Street, New York, New York 10055 (fax: (</font><font style="font-family:'Symbol';font-size:12pt;">2</font><font style="font-family:'Symbol';font-size:12pt;">1</font><font style="font-family:'Symbol';font-size:12pt;">2</font><font style="font-size:12pt;">) 857-3101); Attention: ECM General Counsel and c/o Goldman Sachs &amp; Co. LLC</font><b style="font-size:12pt;font-weight:bold;">,</b><font style="font-size:12pt;"> 200 West Street, New York, New York 10282-2198, Attention: Registration Department. Notices to the Company shall be given to it at 11835 West Olympic Boulevard, Los Angeles, California 90064, Attention: Chief Legal Officer and General Counsel, or by email at francine.sullivan@evgo.com.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:18pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">11.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Fiduciary Relationship</u><font style="font-size:12pt;white-space:pre-wrap;">.  The Company acknowledges and agrees that the Agents is acting solely in the capacity of an arm&#8217;s length contractual counterparty to the Company with respect to the offering of Shares contemplated hereby and any Terms Agreements (including in connection with determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an Agents of, the Company or any other person. Additionally, the Agents is not advising the Company or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company shall consult with its own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions contemplated hereby, and the Agents shall have no responsibility or liability to the Company with respect thereto. Any review by the Agents of the Company, the transactions contemplated hereby or other matters relating to such transactions will be performed solely for the benefit of the Agents and shall not be on behalf of the Company.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:18pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">12.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Adjustments for Stock Splits</u><font style="font-size:12pt;white-space:pre-wrap;">.  The parties acknowledge and agree that all share related numbers contained in this Agreement, any Transaction Proposal and any Transaction Acceptance shall be adjusted to take into account any stock split effected with respect to the Shares.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:18pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">13.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Miscellaneous</u><font style="font-size:12pt;">.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(a)</font></font><i style="font-size:12pt;font-style:italic;">Governing Law</i><font style="font-size:12pt;white-space:pre-wrap;">.   This Agreement, any Terms Agreement and any claim, controversy or dispute arising under or relating to this Agreement or any Terms Agreement shall be governed by, and construed in accordance with, the laws of the State of New York.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(b)</font></font><i style="font-size:12pt;font-style:italic;">Submission to Jurisdiction</i><font style="font-size:12pt;white-space:pre-wrap;">.   The Company hereby submits to the exclusive jurisdiction of the U.S. federal and New York state courts in the Borough of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. The Company waives any objection which it may now or</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">36</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">hereafter have to the laying of venue of any such suit or proceeding in such courts. The Company agrees that final judgment in any such suit, action or proceeding brought in such court shall be conclusive and binding upon the Company and may be enforced in any court to the jurisdiction of which Company is subject by a suit upon such judgment.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(c)</font></font><i style="font-size:12pt;font-style:italic;">Waiver of Jury Trial.</i><font style="font-size:12pt;white-space:pre-wrap;">  Each of the parties hereto hereby waives any right to trial by jury in any suit or proceeding arising out of or relating to this Agreement and any Terms Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:18pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">14.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Persons Entitled to Benefit of Agreement</u><font style="font-size:12pt;white-space:pre-wrap;">.  This Agreement and any Terms Agreement shall inure to the benefit of and be binding upon the parties hereto and thereto, respectively, and their respective successors and the officers, directors, affiliates and controlling persons referred to in Section 9 hereof. Nothing in this Agreement or any Terms Agreement is intended or shall be construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any such Terms Agreement or any provision contained herein or therein. No purchaser of Shares from or through the Agents shall be deemed to be a successor merely by reason of purchase.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:18pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">15.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Counterparts</u><font style="font-size:12pt;white-space:pre-wrap;">.  This Agreement and any Terms Agreement may be signed in counterparts (which may include counterparts delivered by any standard form of telecommunication), each of which shall be an original and all of which together shall constitute one and the same instrument.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:18pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">16.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Survival</u><font style="font-size:12pt;white-space:pre-wrap;">.  The respective indemnities, rights of contribution, representations, warranties and agreements of the Company and the Agents contained in this Agreement or any Terms Agreement or made by or on behalf of the Company or the Agents pursuant to this Agreement or any Terms Agreement or any certificate delivered pursuant hereto or thereto shall survive the delivery of and payment for the Shares and shall remain in full force and effect, regardless of any termination of this Agreement or any Terms Agreement or any investigation made by or on behalf of the Company or the Agents.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:18pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">17.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Certain Defined Terms</u><font style="font-size:12pt;white-space:pre-wrap;">.  For purposes of this Agreement, except where otherwise expressly provided, the term &#8220;affiliate&#8221; has the meaning set forth in Rule 405 under Act; the term &#8220;business day&#8221; means any day other than a day on which banks are permitted or required to be closed in New York City; and the term &#8220;subsidiary&#8221; has the meaning set forth in Rule 405 under the Act.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:18pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">18.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Recognition of the U.S. Special Resolution Regimes</u><font style="font-size:12pt;">.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(a)</font></font><font style="font-size:12pt;">In the event that any Agents that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Agents of this Agreement or any Terms Agreement, and any interest and obligation in or under this Agreement or any Terms Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement or any Terms Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">(b)</font></font><font style="font-size:12pt;">In the event that any Agents that is a Covered Entity or a BHC Act Affiliate of such Agents becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement or any Terms Agreement that may be exercised against such Agents</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">37</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement or any Terms Agreement were governed by the laws of the United States or a state of the United States.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;"><font style="font-size:12pt;">As used in this Section 18:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;"><font style="font-size:12pt;">&#8220;BHC Act Affiliate&#8221; has the meaning assigned to the term &#8220;affiliate&#8221; in, and shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;"><font style="font-size:12pt;">&#8220;Covered Entity&#8221; means any of the following:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 54pt;"><font style="font-size:12pt;">(i) a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b);</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 54pt;"><font style="font-size:12pt;">(ii) a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 54pt;"><font style="font-size:12pt;">(iii) a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;"><font style="font-size:12pt;">&#8220;Default Right&#8221; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;"><font style="font-size:12pt;">&#8220;U.S. Special Resolution Regime&#8221; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:18pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">19.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compliance with USA Patriot Act</u><font style="font-size:12pt;">. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), the Agents is required to obtain, verify and record information that identifies its clients, including the Company, which information may include the name and address of its clients, as well as other information that will allow the Agents to properly identify its clients.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:18pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">20.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Amendments or Waivers</u><font style="font-size:12pt;white-space:pre-wrap;">.  No amendment or waiver of any provision of this Agreement or any Terms Agreement, nor any consent or approval to any departure therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto or thereto as the case may be.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:18pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">21.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Headings</u><font style="font-size:12pt;white-space:pre-wrap;">.  The headings herein and in any Terms Agreement are included for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation of, this Agreement or any Terms Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:12pt;font-weight:bold;">[</b><font style="font-size:12pt;">Signature Page Follows</font><b style="font-size:12pt;font-weight:bold;">]</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">38</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">If the foregoing correctly sets forth the understanding between the Company and the Agents, please so indicate in the space provided below for that purpose, whereupon this letter and your acceptance shall constitute a binding agreement among the Company and the Agents.</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td colspan="2" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:6.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:41.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">&#160;&#160;&#160;&#160;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Very truly yours,</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">EVgo Inc.</b></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">By:</font></p></td><td style="vertical-align:top;width:41.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">/s/ Catherine Zoi</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Name:</font></p></td><td style="vertical-align:top;width:41.41%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Catherine Zoi</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Title:</font></p></td><td style="vertical-align:top;width:41.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Chief Executive Officer</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Accepted and agreed to as of the date first above written:</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">J.P. MORGAN SECURITIES LLC</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:5.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">By:</font></p></td><td style="vertical-align:top;width:42.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">/s/ Sanjeet Dewal</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:5.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Name:</font></p></td><td style="vertical-align:top;width:42.37%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;white-space:pre-wrap;"> Sanjeet Dewal</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:5.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Title:</font></p></td><td style="vertical-align:top;width:42.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;white-space:pre-wrap;"> Managing Director</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Accepted and agreed to as of the date first above written:</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">EVERCORE GROUP L.L.C.</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:5.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">By:</font></p></td><td style="vertical-align:top;width:42.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">/s/ Crystal A. Simpson</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:5.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Name:</font></p></td><td style="vertical-align:top;width:42.37%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Crystal A. Simpson </font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:5.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Title:</font></p></td><td style="vertical-align:top;width:42.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Managing Director </font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">39</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:5.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:42.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:3.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Accepted and agreed to as of the date first above written:</font></p></td><td style="vertical-align:top;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">&#160;&#160;&#160;&#160;</font></p></td><td style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">GOLDMAN SACHS &amp; CO. LLC</font></p></td><td style="vertical-align:top;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:5.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">By:</font></p></td><td style="vertical-align:top;width:42.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">/s/ Charles Park</font></p></td><td style="vertical-align:top;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:5.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Name:</font></p></td><td style="vertical-align:top;width:42.37%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;white-space:pre-wrap;"> Charles Park</font></p></td><td style="vertical-align:top;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:5.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Title:</font></p></td><td style="vertical-align:top;width:42.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;white-space:pre-wrap;"> Managing Director </font></p></td><td style="vertical-align:top;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">40</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">Authorized Company Representatives</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;">Olga Shevorenkova &#8211; Chief Financial Officer</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="display:none;line-height:0pt;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">41</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">EVgo Inc. Common Stock</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:12pt;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">TERMS AGREEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">[&#9679;]</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">J.P. Morgan Securities LLC</font><font style="font-size:12pt;"><br></font><font style="font-size:12pt;">383 Madison Avenue</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">New York, New York 10179</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Evercore Group L.L.C.</font><font style="font-size:12pt;"><br></font><font style="font-size:12pt;">55 East 52</font><sup style="font-size:9pt;vertical-align:top;">nd</sup><font style="font-size:12pt;"> Street</font><font style="font-size:12pt;"><br></font><font style="font-size:12pt;">New York, New York 10055</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Goldman Sachs &amp; Co. LLC</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">200 West Street</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">New York, New York 10282-2198</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">Dear All:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">EVgo Inc., a Delaware corporation (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Company</b><font style="font-size:12pt;">&#8221;), proposes, subject to the terms and conditions stated herein and in the Distribution Agreement dated November 10, 2022 (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Distribution Agreement</b><font style="font-size:12pt;">&#8221;) between the Company and J.P. Morgan Securities LLC, Evercore Group L.L.C. and Goldman Sachs &amp; Co. LLC (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Agents</b><font style="font-size:12pt;">&#8221;), to issue and sell to the Agents the securities specified in the Schedule hereto (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Purchased Securities</b><font style="font-size:12pt;">&#8221;). Unless otherwise defined below, terms defined in the Distribution Agreement shall have the same meanings when used herein.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">Each of the provisions of the Distribution Agreement not specifically related to the solicitation by the Agents, as Agents of the Company, of offers to purchase securities is incorporated herein by reference in its entirety, and shall be deemed to be part of this Terms Agreement to the same extent as if such provisions had been set forth in full herein. Each of the representations, warranties and agreements set forth therein shall be deemed to have been made as of the date of this Terms Agreement and the Settlement Date set forth in the Schedule hereto.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">An amendment to the Registration Statement or a supplement to the Prospectus, as the case may be, relating to the Purchased Securities, in the form heretofore delivered to the Agents, is now proposed to be filed with the Securities and Exchange Commission.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">Subject to the terms and conditions set forth herein and in the Distribution Agreement which are incorporated herein by reference, the Company agrees to issue and sell to the Agents, and the latter agrees to purchase from the Company, the Purchased Securities at the time and place and at the purchase price set forth in the Schedule hereto.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">A-</font><font style="font-size:12pt;">1</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">Notwithstanding any provision of the Distribution Agreement or this Terms Agreement to the contrary, the Company consents to the Agents trading in the Common Stock for Agents&#8217; own account and for the account of its clients at the same time as sales of the Purchased Securities occur pursuant to this Terms Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;font-style:italic;font-weight:bold;">[</font><i style="font-size:12pt;font-style:italic;">Signature Page Follows</i><font style="font-size:12pt;font-style:italic;font-weight:bold;">]</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">A-</font><font style="font-size:12pt;">2</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">If the foregoing is in accordance with your understanding, please sign and return to us a counterpart hereof, whereupon this Terms Agreement, including those provisions of the Distribution Agreement incorporated herein by reference, shall constitute a binding agreement between the Agents and the Company.</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:4.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:43.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">EVgo Inc.</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:4.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">By:</font></p></td><td style="vertical-align:top;width:43.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:4.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:43.34%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Name:</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:4.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:43.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Title:</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Accepted and agreed as of the date first above written:</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">J.P. MORGAN SECURITIES LLC</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:4.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">By:</font></p></td><td style="vertical-align:top;width:43.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:4.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:43.34%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Name:</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:4.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:43.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Title:</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Accepted and agreed as of the date first above written:</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">EVERCORE GROUP L.L.C.</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:4.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">By:</font></p></td><td style="vertical-align:top;width:43.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:4.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:43.34%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Name:</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:4.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:43.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Title:</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:48.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Accepted and agreed as of the date first above written:</font></p></td><td style="vertical-align:top;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">GOLDMAN SACHS &amp; CO. LLC</font></p></td><td style="vertical-align:top;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:4.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">By:</font></p></td><td style="vertical-align:top;width:43.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:4.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:43.34%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Name:</font></p></td><td style="vertical-align:top;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:4.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:43.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Title:</font></p></td><td style="vertical-align:top;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:top;width:48.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">A-</font><font style="font-size:12pt;">3</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:12pt;font-weight:bold;">Schedule to Terms Agreement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Title of Purchased Securities:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">Common Stock, par value $0.0001 per share</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Number of Shares of Purchased Securities:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><b style="font-size:12pt;font-weight:bold;">[</b><font style="font-family:'Symbol';font-size:12pt;">&#183;</font><b style="font-size:12pt;font-weight:bold;">]</b><font style="font-size:12pt;"> shares</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;white-space:pre-wrap;"> Initial Price to Public:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><font style="font-size:12pt;">$</font><b style="font-size:12pt;font-weight:bold;">[</b><font style="font-family:'Symbol';font-size:12pt;">&#183;</font><b style="font-size:12pt;font-weight:bold;">]</b><font style="font-size:12pt;"> per share</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Purchase Price Payable by the Agents:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><font style="font-size:12pt;">$</font><b style="font-size:12pt;font-weight:bold;">[</b><font style="font-family:'Symbol';font-size:12pt;">&#183;</font><b style="font-size:12pt;font-weight:bold;">]</b><font style="font-size:12pt;"> per share</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Method of and Specified Funds for Payment of Purchase Price:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><font style="font-size:12pt;">[By wire transfer to a bank account specified by the Company in same day funds.]</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Method of Delivery:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><font style="font-size:12pt;">[To the Agents&#8217; account, or the account of the Agents&#8217; designee, at The Depository Trust Company via DWAC in return for payment of the purchase price.]</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><font style="font-size:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Settlement Date:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><font style="font-size:12pt;">[&#61623;]</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Closing Location:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><b style="font-size:12pt;font-weight:bold;">[</b><font style="font-family:'Symbol';font-size:12pt;">&#183;</font><b style="font-size:12pt;font-weight:bold;">]</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Documents to be Delivered:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">The following documents referred to in the Distribution Agreement shall be delivered on the Settlement Date as a condition to the closing for the Purchased Securities (which documents shall be dated on or as of the Settlement Date and shall be appropriately updated to cover any Permitted Free Writing Prospectus and any amendments or supplements to the Registration Statement, the Prospectus, any Permitted Free Writing Prospectus and any documents incorporated by reference therein):</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">(1) the officer&#8217;s certificate referred to in Section 5(a)(i);</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">(2) the letters of the Company&#8217;s outside counsel referred to in Section 5(a)(ii);</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">(3) the &#8220;comfort&#8221; letter referred to in Section 5(a)(iii);</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">(4) the letters referred to in Section 5(b); and</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">(5) such other documents as the Agents shall reasonably request.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">Time of sale: </font><b style="font-size:12pt;font-weight:bold;">[</b><font style="font-family:'Symbol';font-size:12pt;">&#183;</font><b style="font-size:12pt;font-weight:bold;">] [</b><font style="font-size:12pt;">a.m./p.m.</font><b style="font-size:12pt;font-weight:bold;">]</b><font style="font-size:12pt;"> (New York City time) on </font><b style="font-size:12pt;font-weight:bold;">[</b><font style="font-family:'Symbol';font-size:12pt;">&#183;</font><b style="font-size:12pt;font-weight:bold;">]</b><font style="font-size:12pt;">, </font><b style="font-size:12pt;font-weight:bold;">[</b><font style="font-family:'Symbol';font-size:12pt;">&#183;</font><b style="font-size:12pt;font-weight:bold;">]</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">Time of sale information:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">A-</font><font style="font-size:12pt;">4</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:12pt;">The number of shares of Purchased Securities set forth above</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:12pt;">The initial price to public set forth above</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-family:'Symbol';">&#183;</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><b style="font-size:12pt;font-weight:bold;">[Other]</b></p></td></tr></table><p style="display:none;line-height:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">A-</font><font style="font-size:12pt;">5</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:12pt;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">OFFICERS&#8217; CERTIFICATE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">Dated _____, 20__</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">We, [name], [title] of EVgo Inc., a Delaware corporation (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Company</b><font style="font-size:12pt;">&#8221;), do hereby certify that this certificate is signed by us pursuant to the Distribution Agreement dated November 10, 2022 between the Company and J.P. Morgan Securities LLC, Evercore Group L.L.C. and Goldman Sachs &amp; Co. LLC (the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Agreement</b><font style="font-size:12pt;">&#8221;), and do hereby further certify on behalf of the Company, as follows:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">1.</font></font><font style="font-size:12pt;">The representations and warranties of the Company in the Agreement are true and correct on and as of the date hereof as though made on and as of this date;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">2.</font></font><font style="font-size:12pt;">The Company has performed all obligations and satisfied all conditions on its part to be performed or satisfied pursuant to the Agreement on or prior to the date hereof;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">3.</font></font><font style="font-size:12pt;">The Company&#8217;s Registration Statement (File No. 333-266753) and any post-effective amendments thereto have become effective under the Act; no stop order suspending the effectiveness of such Registration Statement has been issued and no proceeding for that purpose or pursuant to Section 8A of the Act has been initiated or, to the knowledge of the undersigned, threatened by the Commission; no notice of objection of the Commission to the use of such Registration Statement pursuant to Rule 401(g)(2) under the Act has been received by the Company; and all requests for additional information on the part of the Commission have been complied with; and</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">4.</font></font><font style="font-size:12pt;">Since the respective dates as of which information is given in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus, except as otherwise stated therein, (i) there has not been any change in the capital stock (other than the issuance of shares of Common Stock upon exercise of stock options and warrants described as outstanding in, and the grant of options and awards under existing equity incentive plans described in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus, and the issuance of Shares pursuant to this Agreement) or short-term debt or long-term debt (except for borrowings and the repayment of borrowings in the ordinary course of business) of the Company or any of its subsidiaries, or any dividend or distribution of any kind declared, set aside for payment, paid or made by the Company on any class of capital stock (other than regularly scheduled cash dividends in amounts that are consistent with past practice), or any material adverse change, or any development involving a prospective material adverse change, in or affecting the business, properties, management, financial position, stockholders&#8217; equity, results of operations or prospects of the Company and its subsidiaries taken as a whole; (ii) except as disclosed to the Agents, neither the Company nor any of its subsidiaries has entered into any transaction or agreement (not in the ordinary course of business) that is material to the Company and its subsidiaries taken as a whole or incurred any liability or obligation, direct or contingent, that is material to the Company and its subsidiaries taken as a whole; and (iii) neither the Company nor</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">B-</font><font style="font-size:12pt;">1</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">any of its subsidiaries has sustained any loss or interference with its business that is material to the Company and its subsidiaries taken as a whole and that is either from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor disturbance or dispute or any action, order or decree of any court or arbitrator or governmental or regulatory authority.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">All capitalized terms used herein and not otherwise defined shall have the respective meanings assigned to them in the Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:12pt;font-weight:bold;">[</b><font style="font-size:12pt;">Signature Page Follows</font><b style="font-size:12pt;font-weight:bold;">]</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">B-</font><font style="font-size:12pt;">2</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr><td style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">&#160;&#160;&#160;&#160;</font></p></td><td style="vertical-align:top;width:49.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:49.2%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Name:</font></p></td></tr><tr><td style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:49.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Title:</font></p></td></tr><tr><td style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:49.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:49.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:49.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:49.2%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Name:</font></p></td></tr><tr><td style="vertical-align:top;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:49.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Title:</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">B-</font><font style="font-size:12pt;">3</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">FORM OF OPINION AND NEGATIVE ASSURANCE STATEMENT OF</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">VINSON &amp; ELKINS L.L.P.,</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">COUNSEL TO THE COMPANY</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">1.</font></font><font style="font-size:12pt;">The Company is validly existing as a corporation and in good standing under the laws of the State of Delaware, with corporate power and authority to conduct its business, as described in the Registration Statement and the Final Prospectus and to execute and deliver, and to perform its obligations under, the Equity Sales Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">2.</font></font><font style="font-size:12pt;">The Company is duly qualified to do business and is in good standing as a foreign corporation in the jurisdictions set forth opposite its name on </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</u><font style="font-size:12pt;"> hereto.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">3.</font></font><font style="font-size:12pt;">The Registration Statement has become effective under the Securities Act of 1933 (the &#8220;</font><font style="font-size:12pt;font-style:italic;font-weight:bold;">Act</font><font style="font-size:12pt;">&#8221;); and (i) no stop order suspending the effectiveness of the Registration Statement has been issued and (ii) no proceedings for that purpose have been instituted by the Commission.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">4.</font></font><font style="font-size:12pt;">The Registration Statement, at the time it became effective under the Act, including the information deemed to be a part thereof pursuant to Rule 430B under the Act, and the Final Prospectus as of its date, appeared on their face to comply as to form in all material respects with the requirements of the Act and the rules and regulations thereunder except that in each case we express no opinion with respect to the financial statements or other financial and statistical data derived from the financial statements contained in or omitted from the Registration Statement or Final Prospectus. For purposes of this paragraph, we have assumed that the statements made in the Registration Statement and the Final Prospectus are correct and complete without independent check or verification of the statements contained therein.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">5.</font></font><font style="font-size:12pt;">Any required filing of the Final Prospectus pursuant to Rule 424(b) under the Act has been made in the manner and within the time period required by such Rule.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">6.</font></font><font style="font-size:12pt;">The Equity Sales Agreement has been duly authorized, executed, and delivered by the Company.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">7.</font></font><font style="font-size:12pt;">The Securities have been duly authorized for issuance and, upon approval of the terms of any sale of Securities pursuant to the Equity Sales Agreement by the Authorized Officer pursuant to the Resolutions and payment and delivery in accordance with the Equity Sales Agreement and the Final Prospectus, will be validly issued, fully paid, and nonassessable. The issuance and sale of the Securities are not subject to any preemptive rights, rights of first refusal or other similar rights under the Delaware General Corporation Law (the &#8220;</font><font style="font-size:12pt;font-style:italic;font-weight:bold;">DGCL</font><font style="font-size:12pt;">&#8221;) or the Company&#8217;s Certificate of Incorporation or the By-laws of the Company, except for any such preemptive rights, rights of first refusal, similar rights or similar contractual rights that have been waived.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">8.</font></font><font style="font-size:12pt;">The execution, delivery and performance by the Company of the Equity Sales Agreement, and the issuance and sale of the Securities pursuant to the terms of the Equity Sales</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">C-</font><font style="font-size:12pt;">1</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">Agreement do not: (a) require any consent, approval, license, or exemption by, order or authorization of, or filing, recording or registration by the Company with any Delaware governmental authority pursuant to the DGCL or federal governmental authority, except (i) those that have been obtained or made under the Act, the Exchange Act, or </font><font style="font-size:12pt;">the Financial Industry Regulatory Authority, Inc.</font><font style="font-size:12pt;"> and (ii) periodic and other reporting requirements under the Exchange Act and the and the rules and regulations thereunder; or (b) violate the Certificate of Incorporation or the By-laws, the DGCL, or any federal statute, law, rule, or regulation, or, to our knowledge, any court order, writ, judgment, injunction, award or decree, if any.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">9.</font></font><font style="font-size:12pt;">The statements in the Final Prospectus under the caption &#8220;Description of Securities,&#8221; insofar as such statements contain summaries of documents referenced therein or matters of law, are, in all material respects, accurate summaries and fairly present the information required by the Act and the rules and regulations thereunder with respect to such documents and matters.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">10.</font></font><font style="font-size:12pt;">The Company is not, and solely after giving effect to the issuance of the Securities and the application of the proceeds as described in the Final Prospectus, will not be, required to register as an &#8220;investment company,&#8221; as that term is defined in the Investment Company Act of 1940, as amended.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="display:none;line-height:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">C-</font><font style="font-size:12pt;">2</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Significant Subsidiaries</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0.5pt;padding-right:0.5pt;width:100%;"><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company</u></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Jurisdiction of Organization</u></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">CRIS Thunder Merger LLC</font></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">Delaware</font></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">EVgo OpCo, LLC</font></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">Delaware</font></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">EVgo Holdco, LLC </font></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">Delaware</font></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">EVgo Services LLC</font></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">Delaware</font></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">EVgo Ride Share LLC</font></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">Delaware</font></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">EVgo Recargo HoldCo LLC </font></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">Delaware</font></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">PlugShare LLC</font></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;">California</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="font-size:12pt;">D-</font><font style="font-size:12pt;">1</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>evgo-20221110xex5d1.htm
<DESCRIPTION>EX-5.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 11/10/2022 09:06:52 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 5.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><img src="evgo-20221110xex5d1002.jpg" alt="Graphic" style="display:inline-block;height:15.05pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:127.3pt;"></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">November 10, 2022</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">EVgo Inc.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">11835 W. Olympic Boulevard, Suite 900E</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Los Angeles, CA 90064</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">Ladies and Gentlemen:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">We have acted as counsel to EVgo Inc., a Delaware corporation (the &#8220;</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company</u><font style="font-size:12pt;">&#8221;), with respect to certain legal matters in connection with&#160;the offer and sale from time to time (the &#8220;</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Offering</u><font style="font-size:12pt;">&#8221;) by the Company of shares of the Company&#8217;s Class A Common Stock, par value $0.0001 per share (the &#8220;</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Securities</u><font style="font-size:12pt;">&#8221;), with an aggregate sales price of up to $200,000,000, which may be offered and sold from time to time pursuant to the Equity Distribution Agreement, dated as of November 10, 2022 (the &#8220;</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Equity Distribution Agreement</u><font style="font-size:12pt;">&#8221;), between the Company and J.P. Morgan Securities LLC, Evercore Group L.L.C. and Goldman Sachs &amp; Co. LLC as sales agents (the &#8220;</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Sales Agents</u><font style="font-size:12pt;">&#8221;), a copy of which is being filed with the Securities and Exchange Commission (the &#8220;</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Commission</u><font style="font-size:12pt;">&#8221;) as an exhibit to the Company&#8217;s Current Report on Form 8-K filed on or about the date hereof. The Securities will be offered for sale pursuant to a prospectus supplement dated November 10, 2022 (the &#8220;</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Prospectus Supplement</u><font style="font-size:12pt;">&#8221;), that will be filed with the Commission pursuant to Rule 424(b)(5) on or after November 10, 2022, to a prospectus dated August 25, 2022 (as amended and supplemented by the Prospectus Supplement, the &#8220;</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Prospectus</u><font style="font-size:12pt;">&#8221;) that constitutes a part of the Company&#8217;s Registration Statement on Form S-3 (Registration No. 333-266753), filed with the Commission on August 10, 2022 (the &#8220;</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Registration Statement</u><font style="font-size:12pt;">&#8221;), which Registration Statement was declared effective by the Commission on August 25, 2022.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">In rendering the opinions set forth below, we have reviewed (i) the Equity Distribution Agreement; (ii)&#160;the Registration Statement; (iii)&#160;the Prospectus Supplement; (iv)&#160;the Prospectus; (v)&#160;the Second Amended and Restated Certificate of Incorporation of the Company, as amended; (vi) the Amended and Restated Bylaws of the Company, as amended; (vii)&#160;resolutions adopted by the Board of Directors of the Company and resolutions adopted by the &#160;Pricing Committee of the Company (the &#8220;</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Resolutions</u><font style="font-size:12pt;">&#8221;) relating to the Registration Statement, the Offering, the Equity Distribution Agreement and related matters, including those resolutions authorizing the Chief Financial Officer (the &#8220;</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Authorized Officer</u><font style="font-size:12pt;">&#8221;) to, among other things, effect sales under the Equity Distribution Agreement; and (vii)&#160;such other certificates, statutes and other instruments and documents as we considered appropriate for purposes of the opinions hereafter expressed. In addition, we have reviewed such questions of law as we considered appropriate. As to matters of fact relevant to the opinions expressed below, and as to factual matters arising in connection with our review of corporate documents, records and other documents and writings, we have relied upon certificates and other communications of corporate officers of the Company, without further investigation as to the facts set forth therein.</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:30pt;width:100%;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:99.89%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><img src="evgo-20221110xex5d1001.jpg" alt="Graphic" style="display:inline-block;height:15.05pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:38.29pt;"></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';white-space:pre-wrap;">November  10, 2022   Page </font><font style="font-family:'Arial','Helvetica','sans-serif';">2</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">For purposes of rendering the opinions set forth below, we have made the following assumptions:</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;text-align:justify;"><font style="font-size:12pt;">(i)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;text-align:justify;"><font style="font-size:12pt;">each document submitted to us for review is accurate and complete, each such document that is an original is authentic, each such document that is a copy conforms to an authentic original, and all signatures on each such document are genuine;</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;text-align:justify;"><font style="font-size:12pt;">(ii)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;text-align:justify;"><font style="font-size:12pt;">each person signing the documents that we reviewed has the legal capacity and authority to do so;</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;text-align:justify;"><font style="font-size:12pt;">(iii)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;text-align:justify;"><font style="font-size:12pt;">each certificate from governmental officials reviewed by us is accurate, complete and authentic, and all official public records are accurate and complete;</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;text-align:justify;"><font style="font-size:12pt;">(iv)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;text-align:justify;"><font style="font-size:12pt;">no stop orders suspending the Registration Statement&#8217;s effectiveness will have been issued and remain in effect, in each case, at the time the Securities are offered or issued as contemplated by the Registration Statement and the Prospectus;</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;text-align:justify;"><font style="font-size:12pt;">(v)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;text-align:justify;"><font style="font-size:12pt;">all Securities will be issued and sold in compliance with applicable federal and state securities laws and in the manner stated in the Registration Statement, Prospectus, Prospectus Supplement and Equity Distribution Agreement; and</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;text-align:justify;"><font style="font-size:12pt;">(vi)</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;text-align:justify;"><font style="font-size:12pt;">the Equity Distribution Agreement has been duly authorized and validly executed and delivered by the Sales Agents and constitutes a legal, valid and binding obligation of the Sales Agents, and the Sales Agents have the requisite organizational and legal power and authority to perform its obligations under the Equity Distribution Agreement.</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">Based on the foregoing, and subject to the assumptions, qualifications, limitations and exceptions set forth herein, we are of the opinion that the Securities to be issued and sold by the Company as contemplated by the Equity Distribution Agreement have been duly authorized for issuance and, upon approval of the terms of any sale of Securities pursuant to the Equity Distribution Agreement by the Authorized Officer pursuant to the Resolutions and payment and delivery in accordance with the Equity Distribution Agreement, the Prospectus Supplement and the Prospectus, will be validly issued, fully paid and non-assessable.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">The foregoing opinions are limited in all respects to the Delaware General Corporation Law (including the applicable provisions of the Delaware Constitution and the reported judicial decisions interpreting these laws) and the federal laws of the United States of America as in effect on the date hereof, and we undertake no duty to update or supplement the foregoing opinions to reflect any facts or circumstances that may hereafter come to our attention or to reflect any changes in any law that may hereafter occur or become effective. We express no opinion as to the effect of the laws of any other jurisdiction, domestic or foreign, or to any matter other than as expressly set forth above, and no opinion on any other matter may be inferred or implied herefrom.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:12pt;">We hereby consent to the filing of this opinion as an exhibit to the Company&#8217;s Current Report on Form 8-K, to be filed on or about the date hereof, and to the use of our name in the Prospectus forming a part of the Registration Statement under the caption &#8220;Legal Matters.&#8221; By giving such </font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:30pt;width:100%;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:99.89%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><img src="evgo-20221110xex5d1001.jpg" alt="Graphic" style="display:inline-block;height:15.05pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:38.29pt;"></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';white-space:pre-wrap;">November  10, 2022   Page </font><font style="font-family:'Arial','Helvetica','sans-serif';">3</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">consent, we do not admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission thereunder.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 216pt;"><font style="font-size:12pt;">Very truly yours,</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 216pt;">/s/ Vinson &amp; Elkins L.L.P.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 216pt;">Vinson &amp; Elkins L.L.P.</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>evgo-20221110xex5d1001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 evgo-20221110xex5d1001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  ? $T# 2(  A$! Q$!_\0
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'U+\G_D?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>evgo-20221110xex5d1002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 evgo-20221110xex5d1002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  ? /\# 2(  A$! Q$!_\0
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M>ER+.D$0',DCJ2JCH!SDDUVM]$L6GW6T!<QN3@8YP:P]I):-?@=7LH/WHO\
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0\=.YR_"KX:6M_A>W_ /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>evgo-20221110.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.1.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 11/10/2022 9:06:59 PM-->
<!--Modified on: 11/10/2022 9:06:59 PM-->
<xsd:schema targetNamespace="http://www.deitaxonomy.com/20221110" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:srt-roles="http://fasb.org/srt-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt="http://fasb.org/srt/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:attributeFormDefault="unqualified" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:evgo="http://www.deitaxonomy.com/20221110" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:cef="http://xbrl.sec.gov/cef/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.deitaxonomy.com/role/DisclosureStandardAndCustomAxisDomainDefaults" id="DisclosureStandardAndCustomAxisDomainDefaults">
        <link:definition>99900 - Disclosure - Standard And Custom Axis Domain Defaults</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="evgo-20221110_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="evgo-20221110_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="evgo-20221110_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://xbrl.sec.gov/cef/2022" schemaLocation="https://xbrl.sec.gov/cef/2022/cef-2022.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xsd:element id="evgo_RedeemableWarrantsForClassCommonStockMember" name="RedeemableWarrantsForClassCommonStockMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>evgo-20221110_def.xml
<DESCRIPTION>EX-101.DEF
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.1.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 11/10/2022 9:06:59 PM-->
<!--Modified on: 11/10/2022 9:06:59 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="evgo-20221110.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" />
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DisclosureStandardAndCustomAxisDomainDefaults" xlink:href="evgo-20221110.xsd#DisclosureStandardAndCustomAxisDomainDefaults" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/DisclosureStandardAndCustomAxisDomainDefaults" xlink:type="extended" xlink:title="99900 - Disclosure - Standard And Custom Axis Domain Defaults">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis_1" xlink:title="dei_LegalEntityAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_1" xlink:title="dei_EntityDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="dei_LegalEntityAxis_1" xlink:to="dei_EntityDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:dei_LegalEntityAxis_1 To dei_EntityDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_1" xlink:title="us-gaap_StatementClassOfStockAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_1" xlink:title="us-gaap_ClassOfStockDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_StatementClassOfStockAxis_1" xlink:to="us-gaap_ClassOfStockDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_StatementClassOfStockAxis_1 To us-gaap_ClassOfStockDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_1" xlink:title="us-gaap_ClassOfWarrantOrRightAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_1" xlink:title="us-gaap_ClassOfWarrantOrRightDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_1" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_ClassOfWarrantOrRightAxis_1 To us-gaap_ClassOfWarrantOrRightDomain_1" order="1" />
  </link:definitionLink>
  <definitionLink xlink:role="http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" use="optional" />
    <loc xlink:type="locator" xlink:href="evgo-20221110.xsd#evgo_RedeemableWarrantsForClassCommonStockMember" xlink:label="evgo_RedeemableWarrantsForClassCommonStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="evgo_RedeemableWarrantsForClassCommonStockMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="18" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="19" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="20" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="21" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="22" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="23" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="24" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="25" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" priority="1" use="optional" />
  </definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>evgo-20221110_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.1.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 11/10/2022 9:06:59 PM-->
<!--Modified on: 11/10/2022 9:06:59 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Stock [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Stock [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Class A [Member]</label>
    <loc xlink:type="locator" xlink:href="evgo-20221110.xsd#evgo_RedeemableWarrantsForClassCommonStockMember" xlink:label="evgo_RedeemableWarrantsForClassCommonStockMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="evgo_RedeemableWarrantsForClassCommonStockMember" xlink:to="evgo_RedeemableWarrantsForClassCommonStockMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="evgo_RedeemableWarrantsForClassCommonStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Redeemable Warrants for Class A Common Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="evgo_RedeemableWarrantsForClassCommonStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Redeemable Warrants for Class A Common Stock [Member]</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>evgo-20221110_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.1.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 11/10/2022 9:06:59 PM-->
<!--Modified on: 11/10/2022 9:06:59 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="evgo-20221110.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#N2" roleURI="http://xbrl.sec.gov/cef/role/N2" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable_638037112192781523" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentInformationTable_638037112192781523" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638037112192781523" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable_638037112192781523" xlink:to="us-gaap_StatementClassOfStockAxis_638037112192781523" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638037112192781523" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638037112192781523" xlink:to="us-gaap_ClassOfStockDomain_638037112192781523" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_638037112192781523" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638037112192781523" xlink:to="us-gaap_CommonClassAMember_638037112192781523" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="evgo-20221110.xsd#evgo_RedeemableWarrantsForClassCommonStockMember" xlink:label="evgo_RedeemableWarrantsForClassCommonStockMember_638037112192781523" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638037112192781523" xlink:to="evgo_RedeemableWarrantsForClassCommonStockMember_638037112192781523" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems_638037112192791531" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable_638037112192781523" xlink:to="dei_DocumentInformationLineItems_638037112192791531" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638037112192791531" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_DocumentType_638037112192791531" order="1" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638037112192791531" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_DocumentPeriodEndDate_638037112192791531" order="2" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638037112192791531" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_EntityFileNumber_638037112192791531" order="3" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638037112192791531" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_EntityRegistrantName_638037112192791531" order="4" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638037112192791531" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_EntityIncorporationStateCountryCode_638037112192791531" order="5" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638037112192791531" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_EntityTaxIdentificationNumber_638037112192791531" order="6" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638037112192791531" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_EntityAddressAddressLine1_638037112192791531" order="7" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2_638037112192791531" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_EntityAddressAddressLine2_638037112192791531" order="8" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638037112192791531" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_EntityAddressCityOrTown_638037112192791531" order="9" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_638037112192791531" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_EntityAddressStateOrProvince_638037112192791531" order="10" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638037112192791531" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_EntityAddressPostalZipCode_638037112192791531" order="11" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638037112192801524" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_CityAreaCode_638037112192801524" order="12" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638037112192801524" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_LocalPhoneNumber_638037112192801524" order="13" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_638037112192801524" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_WrittenCommunications_638037112192801524" order="14" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_638037112192801524" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_SolicitingMaterial_638037112192801524" order="15" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_638037112192801524" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_PreCommencementTenderOffer_638037112192801524" order="16" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_638037112192801524" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_PreCommencementIssuerTenderOffer_638037112192801524" order="17" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638037112192801524" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_Security12bTitle_638037112192801524" order="18" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638037112192801524" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_TradingSymbol_638037112192801524" order="19" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638037112192801524" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_SecurityExchangeName_638037112192801524" order="20" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638037112192811522" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_EntityEmergingGrowthCompany_638037112192811522" order="21" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod_638037112192811522" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_EntityExTransitionPeriod_638037112192811522" order="22" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638037112192811522" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_EntityCentralIndexKey_638037112192811522" order="23" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638037112192811522" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_638037112192791531" xlink:to="dei_AmendmentFlag_638037112192811522" order="24" use="optional" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/cef/role/N2" xlink:type="extended" xlink:title="995470 - Disclosure - N-2" xmlns="http://www.xbrl.org/2003/linkbase" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140028842892464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 10, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 10,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">001-39572<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EVgo Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">85-2326098<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">11835 West Olympic Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 900E<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los Angeles<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90064<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">877<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">494-3833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001821159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Shares of Class A common stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EVGO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=evgo_RedeemableWarrantsForClassCommonStockMember', window );">Redeemable Warrants for Class A Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EVGOW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=evgo_RedeemableWarrantsForClassCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=evgo_RedeemableWarrantsForClassCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140028842686368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>N-2<br></strong></div></th>
<th class="th"><div>Nov. 10, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001821159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">001-39572<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EVgo Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">11835 West Olympic Boulevard<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 900E<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los Angeles<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90064<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">877<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">494-3833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>evgo-20221110x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:evgo="http://www.deitaxonomy.com/20221110"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="evgo-20221110.xsd" xlink:type="simple"/>
    <context id="Duration_11_10_2022_To_11_10_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_ev6bO2MilkqMaKdp7dSOtA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001821159</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-10</startDate>
            <endDate>2022-11-10</endDate>
        </period>
    </context>
    <context id="Duration_11_10_2022_To_11_10_2022_us-gaap_StatementClassOfStockAxis_evgo_RedeemableWarrantsForClassCommonStockMember_iLzXOQ-tWEyaN1haO_HNkA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001821159</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">evgo:RedeemableWarrantsForClassCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-10</startDate>
            <endDate>2022-11-10</endDate>
        </period>
    </context>
    <context id="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001821159</identifier>
        </entity>
        <period>
            <startDate>2022-11-10</startDate>
            <endDate>2022-11-10</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Tc_VzNCGOKRwE-ygZSqe1pCHA_2_1">0001821159</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Tc_QqXl-2SUOkGwxPCP2xYIgw_3_1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Narr_EHx7cgsh90-FlcN0VPZjOQ">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Narr_o7rTK0RyZEO8kRZeEgcvQg">2022-11-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Narr_ugoQOZFHrkO2bb2rLRLKfQ">EVgo Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Tc_KTkj-axMB0KgSjvk9xBgOQ_1_0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Tc_3KQeXlzP40Gj_bn9Qsv0qw_1_2">001-39572</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Tc_hFMTWYwLxki_woS8Sg7MvA_1_4">85-2326098</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Narr_c2QX8VUWH06DHtz0p03ZUQ">11835 West Olympic Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Narr_L0tRL59vaUyu0h45cQJENQ">Suite 900E</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Narr_Brt6eEusP0qG1Ox3ubPChg">Los Angeles</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Narr_BXNup94HCE6UYxoXJwYntg">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Tc_1pNV0pFBpUup_gt05130OA_1_2">90064</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Narr_dx6xTN2Bikint62PHGMTSA">877</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Narr_AfOY9U0qWUyUxprroZRwEw">494-3833</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Narr_ZUsE1nGBYkuraBafWENOhQ">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Narr_4WMCrSGR8EKfbgSBy-9ynA">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Narr_X4r8q3hHOE-GMNpZsmZ4sg">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Narr_76-DymO58EW4NWdiW7xlCQ">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_11_10_2022_To_11_10_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_ev6bO2MilkqMaKdp7dSOtA"
      id="Narr_EO2x77n3wki4eO5zNOOnHQ">Shares of Class A common stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_11_10_2022_To_11_10_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_ev6bO2MilkqMaKdp7dSOtA"
      id="Tc_ufmRMHGbSEa8iVptZFrfxQ_2_1">EVGO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_11_10_2022_To_11_10_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_ev6bO2MilkqMaKdp7dSOtA"
      id="Narr_aeLmOl02mkmJFSAB4RJ4Xw">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="Duration_11_10_2022_To_11_10_2022_us-gaap_StatementClassOfStockAxis_evgo_RedeemableWarrantsForClassCommonStockMember_iLzXOQ-tWEyaN1haO_HNkA"
      id="Narr_nnxNPqyQ9km2tnxhj9TjpA">Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_11_10_2022_To_11_10_2022_us-gaap_StatementClassOfStockAxis_evgo_RedeemableWarrantsForClassCommonStockMember_iLzXOQ-tWEyaN1haO_HNkA"
      id="Tc_ajFZWZC6zEaVu7jK0PCSFw_3_1">EVGOW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_11_10_2022_To_11_10_2022_us-gaap_StatementClassOfStockAxis_evgo_RedeemableWarrantsForClassCommonStockMember_iLzXOQ-tWEyaN1haO_HNkA"
      id="Narr_I_j67TS15ECrTaQ7ewaHFQ">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Narr_LK4-Az8t-kS-N5aOK7KizQ">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ"
      id="Narr_ETnEpOihf0e5ydRF8JZxYA">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( #.":E4'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  S@FI55.H&<>T    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)OITEAA=#M1?&D(+B@> N3V=U@TX1DI-VWMZV[740?P&-F_GSS
M#4R#46-(])Q"I,2.\LWHNSYKC%MQ9(X:(..1O,GEE.BGYCXD;WAZI@-$@Q_F
M0*"J:@.>V%C#!F9@$5>B:!N+&A,9#NF,M[CBXV?J%IA%H(X\]9Q!EA)$.T^,
MI[%KX J884S)Y^\"V96X5/_$+AT0Y^28W9H:AJ$<ZB4W[2#A[>GQ95FW<'UF
MTR--O[+3?(JT%9?)K_7=_>Y!M*I2JI"RD-5.22UO=;UYGUU_^%V%?;!N[_ZQ
M\46P;>#77;1?4$L#!!0    ( #.":E697)PC$ 8  )PG   3    >&PO=&AE
M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?
MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@
MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?<D3$L/<@HL(2W@4R]9<
MX%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A T%116F]?(+3E'S/X%<M4C66C 1-7
M02:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1
MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP
M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?=
MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP
M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%,
M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I
MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E
M,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ
MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A
M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\
M'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G-- \)0O)/I*D8]ILR.G=";-Z#,:
MP4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:
M<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.BY 1
MOQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR- >C
MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_
M+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?
MP.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"<M4TV4WBA*>
M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT
ML<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3
M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'
M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\
M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^
M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\X^;'
M<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!
M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0
M!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L P%(1=R
MX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+
MPWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83
M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'
M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M70=\OE+*'@-7V36%^>1_4$L#!!0    ( #.":E6?H!OPL0(  .(,   -
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MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^
MKSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE
M?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  S@FI55.H&<>T    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    "  S
M@FI5F5R<(Q &  "<)P  $P              @ '+ 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( #.":E4XD&AZ2P4  /P6   8
M  " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    "  S
M@FI5KG[3BUD#  "D"P  &               @(&-#0  >&PO=V]R:W-H965T
M<R]S:&5E=#(N>&UL4$L! A0#%     @ ,X)J59^@&_"Q @  X@P   T
M         ( !'!$  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  S@FI5EXJ[
M',     3 @  "P              @ 'X$P  7W)E;',O+G)E;'-02P$"% ,4
M    "  S@FI5#6'@AU !  #% @  #P              @ 'A%   >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ ,X)J58WW+%JT    B0(  !H
M     ( !7A8  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ ,X)J56ZG)+P> 0  5P0  !,              ( !2A<  %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&      H "@"$ @  F1@

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="evgo-20221110x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="evgo-20221110x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="evgo-20221110x8k.htm">evgo-20221110x8k.htm</File>
    <File>evgo-20221110.xsd</File>
    <File>evgo-20221110_def.xml</File>
    <File>evgo-20221110_lab.xml</File>
    <File>evgo-20221110_pre.xml</File>
    <File>evgo-20221110xex1d1.htm</File>
    <File>evgo-20221110xex5d1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "evgo-20221110x8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "evgo-20221110_def.xml"
     ]
    },
    "inline": {
     "local": [
      "evgo-20221110x8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "evgo-20221110_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "evgo-20221110_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "evgo-20221110.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/cef/2022/cef-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022_lab.xsd"
     ]
    }
   },
   "elementCount": 205,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 1,
   "memberStandard": 1,
   "nsprefix": "evgo",
   "nsuri": "http://www.deitaxonomy.com/20221110",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "evgo-20221110x8k.htm",
      "contextRef": "Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00090 - Document - Document and Entity Information",
     "role": "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "evgo-20221110x8k.htm",
      "contextRef": "Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ",
      "decimals": null,
      "lang": "en-US",
      "name": "dei:DocumentPeriodEndDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "evgo-20221110x8k.htm",
      "contextRef": "Duration_11_10_2022_To_11_10_2022_h29li1ncIUSgeFRRnzmQbQ",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityFileNumber",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "995470 - Disclosure - N-2",
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "shortName": "N-2",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 2,
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AllRisksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "localname": "AllRisksMember",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "cef_AllSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Securities:"
       }
      }
     },
     "localname": "AllSecuritiesMember",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "localname": "AnnualCoverageReturnRatePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AnnualDividendPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "localname": "AnnualDividendPayment",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_AnnualDividendPaymentCurrent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "localname": "AnnualDividendPaymentCurrent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_AnnualDividendPaymentInitial": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "localname": "AnnualDividendPaymentInitial",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_AnnualExpensesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "localname": "AnnualExpensesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "localname": "AnnualInterestRateCurrentPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AnnualInterestRateInitialPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "localname": "AnnualInterestRateInitialPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AnnualInterestRatePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "localname": "AnnualInterestRatePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_BdcFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "localname": "BdcFileNumber",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "localname": "BusinessDevelopmentCompanyFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_CapitalStockTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "localname": "CapitalStockTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_DistributionServicingFeesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "localname": "DistributionServicingFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "localname": "EffectsOfLeverageTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_EffectsOfLeverageTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "localname": "EffectsOfLeverageTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ExpenseExampleTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "localname": "ExpenseExampleTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ExpenseExampleYear01": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "localname": "ExpenseExampleYear01",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_ExpenseExampleYears1to10": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "localname": "ExpenseExampleYears1to10",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_ExpenseExampleYears1to3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "localname": "ExpenseExampleYears1to3",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_ExpenseExampleYears1to5": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "localname": "ExpenseExampleYears1to5",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_FeeTableAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "localname": "FeeTableAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_FinancialHighlightsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "localname": "FinancialHighlightsAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_HighestPriceOrBid": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "localname": "HighestPriceOrBid",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_HighestPriceOrBidNav": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "localname": "HighestPriceOrBidNav",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "localname": "IncentiveAllocationMaximumPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "localname": "IncentiveAllocationMinimumPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveAllocationPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "localname": "IncentiveAllocationPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveFeesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "localname": "IncentiveFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "localname": "InterestExpensesOnBorrowingsPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IntervalFundFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "localname": "IntervalFundFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LatestNav": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest NAV"
       }
      }
     },
     "localname": "LatestNav",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "localname": "LatestPremiumDiscountToNavPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_LatestSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Share Price"
       }
      }
     },
     "localname": "LatestSharePrice",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LoanServicingFeesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "localname": "LoanServicingFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtPrincipal": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "localname": "LongTermDebtPrincipal",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtStructuringTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "localname": "LongTermDebtTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtTitleTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LowestPriceOrBid": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "localname": "LowestPriceOrBid",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LowestPriceOrBidNav": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "localname": "LowestPriceOrBidNav",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ManagementFeesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "localname": "ManagementFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_NetExpenseOverAssetsPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "localname": "NetExpenseOverAssetsPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "localname": "NewCefOrBdcRegistrantFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_NoPublicTradingTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "localname": "NoPublicTradingTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_NoTradingHistoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "localname": "NoTradingHistoryTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherAnnualExpense1Percent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": 1.0,
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpense1Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherAnnualExpense2Percent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": 2.0,
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpense2Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherAnnualExpense3Percent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": 3.0,
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpense3Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherAnnualExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherAnnualExpensesAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_OtherAnnualExpensesPercent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherExpensesNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "localname": "OtherExpensesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherFeederFundExpensesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "localname": "OtherFeederFundExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherMasterFundExpensesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "localname": "OtherMasterFundExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "localname": "OtherSecuritiesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "localname": "OtherSecurityDescriptionTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherSecurityTitleTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "localname": "OtherSecurityTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherTransactionExpense1Percent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": 1.0,
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpense1Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionExpense2Percent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": 2.0,
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpense2Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionExpense3Percent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": 3.0,
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpense3Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherTransactionExpensesAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_OtherTransactionExpensesPercent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "localname": "OtherTransactionFeesBasisMaximum",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "localname": "OtherTransactionFeesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "localname": "OutstandingSecuritiesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "localname": "OutstandingSecurityAuthorizedShares",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sharesItemType"
    },
    "cef_OutstandingSecurityHeldShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "localname": "OutstandingSecurityHeldShares",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sharesItemType"
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "localname": "OutstandingSecurityNotHeldShares",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sharesItemType"
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "localname": "OutstandingSecurityTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_PrimaryShelfFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "localname": "PrimaryShelfFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "localname": "PrimaryShelfQualifiedFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_ProspectusLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "localname": "ProspectusLineItems",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "xbrltype": "stringItemType"
    },
    "cef_ProspectusTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "localname": "ProspectusTable",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RegisteredClosedEndFundFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "localname": "RegisteredClosedEndFundFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_ReturnAtMinusFivePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "localname": "ReturnAtMinusFivePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtMinusTenPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "localname": "ReturnAtMinusTenPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtPlusFivePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "localname": "ReturnAtPlusFivePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtPlusTenPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "localname": "ReturnAtPlusTenPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtZeroPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "localname": "ReturnAtZeroPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RiskAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "localname": "RiskAxis",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_RiskFactorsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "localname": "RiskFactorsTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RiskTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "localname": "RiskTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SalesLoadPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "localname": "SalesLoadPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_SecurityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security [Axis]"
       }
      }
     },
     "localname": "SecurityAxis",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_SecurityDividendsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "localname": "SecurityDividendsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "localname": "SecurityLiabilitiesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "localname": "SecurityLiquidationRightsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityTitleTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "localname": "SecurityTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityVotingRightsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "localname": "SecurityVotingRightsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "localname": "SeniorSecuritiesAmount",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesCoveragePerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "localname": "SeniorSecuritiesCoveragePerUnit",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Involuntary Liquidating Preference per Unit"
       }
      }
     },
     "localname": "SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SharePriceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "localname": "SharePriceTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_TotalAnnualExpensesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "localname": "TotalAnnualExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_UnderwritersCompensationPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "localname": "UnderwritersCompensationPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "localname": "WarrantsOrRightsCalledAmount",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateItemType"
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "localname": "WarrantsOrRightsExercisePrice",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "dei_AdditionalSecurities462b": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "localname": "AdditionalSecurities462b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "localname": "AdditionalSecurities462bFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "localname": "AdditionalSecuritiesEffective413b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.",
        "label": "Approximate Date of Commencement of Proposed Sale to Public"
       }
      }
     },
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateOrAsapItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r7",
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DelayedOrContinuousOffering": {
     "auth_ref": [
      "r9",
      "r10",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "localname": "DelayedOrContinuousOffering",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "auth_ref": [
      "r9",
      "r10",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EffectiveAfter60Days486a": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "localname": "EffectiveAfter60Days486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveOnDate486a": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "localname": "EffectiveOnDate486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EffectiveOnDate486b": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "localname": "EffectiveOnDate486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EffectiveOnSetDate486a": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "localname": "EffectiveOnSetDate486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveOnSetDate486b": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "localname": "EffectiveOnSetDate486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveUponFiling462e": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "localname": "EffectiveUponFiling462e",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveUponFiling486b": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "localname": "EffectiveUponFiling486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "localname": "EffectiveWhenDeclaredSection8c",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Securities Act File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInvCompanyType": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).",
        "label": "Entity Inv Company Type"
       }
      }
     },
     "localname": "EntityInvCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "invCompanyType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_ExhibitsOnly462d": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "localname": "ExhibitsOnly462d",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "localname": "ExhibitsOnly462dFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_InvestmentCompanyActFileNumber": {
     "auth_ref": [
      "r10",
      "r11",
      "r12",
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "localname": "InvestmentCompanyActFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_InvestmentCompanyActRegistration": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "localname": "InvestmentCompanyActRegistration",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "localname": "InvestmentCompanyRegistrationAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation",
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "auth_ref": [
      "r10",
      "r11",
      "r12",
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "localname": "NewEffectiveDateForPreviousFiling",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_NoSubstantiveChanges462c": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "localname": "NoSubstantiveChanges462c",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "localname": "NoSubstantiveChanges462cFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_PostEffectiveAmendment": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "localname": "PostEffectiveAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PostEffectiveAmendmentNumber": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective.",
        "label": "Post-Effective Amendment Number"
       }
      }
     },
     "localname": "PostEffectiveAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreEffectiveAmendment": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "localname": "PreEffectiveAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreEffectiveAmendmentNumber": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective.",
        "label": "Pre-Effective Amendment Number"
       }
      }
     },
     "localname": "PreEffectiveAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "evgo_RedeemableWarrantsForClassCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Warrants for Class A Common Stock [Member]",
        "label": "Redeemable Warrants for Class A Common Stock [Member]"
       }
      }
     },
     "localname": "RedeemableWarrantsForClassCommonStockMember",
     "nsuri": "http://www.deitaxonomy.com/20221110",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class A [Member]"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Form N-2",
   "Publisher": "SEC"
  },
  "r11": {
   "Name": "Form N-3",
   "Publisher": "SEC"
  },
  "r12": {
   "Name": "Form N-4",
   "Publisher": "SEC"
  },
  "r13": {
   "Name": "Form N-6",
   "Publisher": "SEC"
  },
  "r14": {
   "Name": "Form S-3",
   "Publisher": "SEC"
  },
  "r15": {
   "Name": "Investment Company Act",
   "Number": "270",
   "Publisher": "SEC"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "313"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "413",
   "Subsection": "b"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r20": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "b"
  },
  "r21": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "c"
  },
  "r22": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "d"
  },
  "r23": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "e"
  },
  "r24": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "486",
   "Subsection": "a"
  },
  "r25": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "486",
   "Subsection": "b"
  },
  "r26": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r27": {
   "Name": "Securities Act",
   "Publisher": "SEC",
   "Section": "8",
   "Subsection": "c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r7": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r8": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r9": {
   "Name": "Form F-3",
   "Publisher": "SEC"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001558370-22-017426-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-22-017426-xbrl.zip
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M'$/D!3 8'DF S<.+:O;+!] &[0;P=6@O'LFI*\\/R$<H5#F8K$W\&V6ZUQB
M1FED^>VW-\E];Q_NWQ[2G&'*Y&JGQ3Y85NRUELF" (UD6IO.(ZK-CZ.+/AY]
MTU)0B" ]"2A?-O+UGC[R&GB4"%F\7 =ZDAM:'$W5EW5[0#GRAY9@4:TE?7>=
MGJ3'"EWBYA;S8U]%8N!M9\$]D@!D->M?R76M@N:<79-\GQR&[UP$;1$?E_C?
M<(!^1(:EP6S2)-U_U:.["+Y=IA_0%'.A%J,?,#2-<+-9DXR?'H+Q? #MLCXB
M'F5SRC1R73-?TH@(]GI)_7(1MMS5I":?#J')EGC:E>@)+D>^# =/</R>QI;Y
MJ-2^25G^/H0LI9&T*\B%[S,DMRSQAXK!+17#:-ND$)\/(80QBO<F0N\-(O2:
M%:%_'!%Z[T2$2_GUCCW11?D#5X-EH\<4W0,JD WB7?"O5ZP[=L_H"XY?<JL4
MH6#>J!(U]\G5D;P+.>XI%S#X#\\K:RBS<:-2U-P@5\71EA J-R\8@B74;S8W
M2G;-W?$F\K;H5:\*!_<S2LHWQ4631FFNN2LNHF^+ZI^R4X&(.I"-2%+_FLX]
M2^P:);WFQK@DA+:8?Z0!]B1E9'HKEQ>&UT_9,[2;C!KEO.;&UX2_+<+O&5+:
M([F$ZP-7]42>W4TFQOFERKA1 6IN<:OB>"="C#B/$'N3'(9;&A6EYG9W>S2M
M34K(BU2_;F_\I-Y1,4U)!9-&J:^YR2VB;XOJ)P;5/X@]OH9C:IKZ<^V-/M*J
MN8_-06][,%\OO1DD4U1RXF\V:Y3OFKM5<P3M[E*O0\2F<A#\P^A"S.1T-X?D
MM72;6F+=J @'V:>6!-*R%DN9D81K N/GGN5"&$P;5:'F!K8\BG8EN)3X&0Q&
M<HU??D?EB5"P:Y3\@SSL+830%O,7$K>OL'\+X-3 >*Z]4:9K[F5ST+<R?.;D
M7X%.WHQ6?]3KPN?_ U!+ P04    "  S@FI5(UIT4)@"  !8#@  %0   &5V
M9V\M,C R,C$Q,3!?;&%B+GAM;-57T6[:,!1]K[1_N,N>'1-0IQ$!%>VT)]"F
MLFF5J@DYB0-1'1O9IK"_G^W$#%1H4[JM[ 6%ZW//O>?Z)+)[%^N2P3V5JA"\
M'T1A*P#*4Y$5?-8/ECI''X*+P9NSWEN$;BZO1Y")=%E2KB&5E&B:P:K0<_@J
M%@O"84RE+!B#2UED,PH0M4+#&'8 H8&CN"3*I @.CJL=1G[AJF83/(8HPE$+
MMUOM-G3CUOOXO M?QAXX-JWEQ9-(5O"[V/XDIB(8C5S%:U7T@[G6BQCCU6H5
MKCJAD#.3WHKPS7@T2>>T)*C@2A.>T@ ,/E8N.!(IT6Y 6^GK1#)/T,&;6@<1
M]A_R,&1#*&JC3A2N51;4+=KE!D4\W*YF>I.P#3['U>(&^H"ZEA]UNUWL5H/!
M&4 ].9)0-C)/X%9B_7-!^P%=:\HS:KMU42D8?:1;NXPWQ)9:I#M\S(Y52$\W
MES2OZ)07DQ.5.,*E0C-"%FZO,65:^0BR$3O"=W5@.M'&2=:B5XPH]3F?:)'>
M#=>%\G6<.&/N!G@[ND;[@;U$RSV4NSJ)3'UM\_C$U&H$3H4QX4(CQ^C3<RG*
M9IU7Y44#\)0E[&BI.SHE56(IW:O3W!_;\IKNS*9EDV&_4Y2C;Y-G:!@X0A Y
M.$JXM:0_>E4S_]2LV\H^BI(4_, L]@)/VYZ'M6W[\B'J= WY2*]_RHD5[>MX
M492EX*ZAX9B6"96'QK />.)>/*AMQXL/4"?LQ<.]'NU%1PF5)8=P6]$>XT5Z
M/Q/.8%%DSH#69#8RO:89-<>IA-'O1$K"M?HDI"M7E7;OP%[K'9%^FH8\=@[6
MIL_-?5WS^IN".SF_<#M?;.W?M< 7@US(C==KZ]<?X?W&_VNO]'\WC1[>O268
M"Q?>N7$-?@%02P,$%     @ ,X)J5<:,ERNH!0  :SD  !4   !E=F=O+3(P
M,C(Q,3$P7W!R92YX;6SEFUUOXC@4AN]'VO_@S5Z'?%#:@DI'E+8KM/U A=6,
M]J8RB0%K$CNR3:'_?NT0MT 2"&QG0K,W;;!/CL_KQ[&=D^3BZR(,P MB'%/2
M-IR:;0!$/.IC,FD;,S$VSXVOE[]]N?C=-+]?/=T!GWJS$!$!/(:@0#Z88S$%
M0QI%D(![Q!@. G#%L#]! #AV37JLU8%I7L8NKB"7IU "8E]NS=$5W<0;)2W@
M.)9C6Z[MNJ#9LD];C2;HWVO#>QG:&.^T###YT5)_1K)%(#42WEIPW#:F0D0M
MRYK/Y[5YO4;91)YN.];W^[N!-T4A-#'A A(/&4#:MWA<>$<]*.(.6CE],6*!
M=E"WWMK*M5"_3&UFJB+3<<VZ4UMPWTA"5-4%&M'FJA9OL5_1LK1/^4_ZP&DV
MFU9<:UQ^ >""T0 ]H3&(BUKB-4)M@^,P"I2KN&S*T+AMH)<)-57_.XYD+87\
M<9V,#_V_0_P;(K!X[9$Q96'<C090_O]^ZJV%XB,LX((2&K[6/!I:RL8JYBY6
M5ZC?K+WD*8=<>HR]<>35)O3%\M X'G+J(-8>ZWYPTZI2I\62E.6^ 4<,<:D^
MEGLGZY(HE;\/Z\.5OD +@8B/_+=2+%1#MFTW;6 "[6CU$!(?++V"P] HG5)I
M0+VU4 )UZ5%6@(O4ON0B#]ZYR!_/72HGN,Z("P8]H3T%<(2"MK%19_W$,'1?
MK?3/$([>QUP2T3;3Y]/ZN5T_<QS7:;IGYT[#K;_'O#I(.FP]?L@\W8P\3(V;
M=2:)A15!)OV9WA0';T-AS&B8ZK6D)7I \)3YB,F%QP S+F.BD3*'@0$BABF3
MPZEMN/\%RQCR4:QLQLT)A-&2#0H$UR7OD)*"YX'L0Z04= /(^>-X(*CWH[/
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M"3!*Z9NSTX;>83TJS$,+V%\^MZ=0+PMR=H8]S*7LD0W9P]S8W>DP:NSN]%A
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M"V&4)<QN\)H@VK0>"AS(Z3K'D :#9!U>WFS@( (1!CD$.A"2K0J443- 2*5
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MT2; I[ ><'P(Q1BJ<BEZ*:MKAI'FRX/@HW-0./^K'-!M8UR5:DN;.SZN@"]
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M&(7&8%UN*BKLKW=O<A!(TON!N_=!T__4</?E%XAV1\:9%A_:%79OK7MMB%Z
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M&Q1>VC4Q\\N<7;&X"8))PA\F6:<7A(O+:LC!=0'M;A!2/3410["(5G;C.&A
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MDC"N)F 'K"_,ZU)9#F+;'5G!=/IJOEL)WS$3!)+9!13C(,);,(JY:J.&8^M
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MS\E%]J#F:2B+MNY8NHH&KNU[@SUF&UR#WM.^SXM>E48;*1 ?*'Y\M^B%=OC
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MF@SG(/K;TI*C1Y;P%(,V*#0/*=_ ^V25L'24TA76!7#\[P-G$\MO>%KU0IG
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M-H>YUBC=MX^RFR@G:'(*9>QE7YW].4&T!8.G$ZJEP]08".U^_$N#NP.D7KB
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M[W.0$CWR4?OBCFFP,S8%J>X.MV_7C""F#"NMQ9?(;#>RHZE$^#>UT*I<,ZB
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MK<&V4R6U;<\7-VFKHH.8U#TU$HP47W-Y$-M1R3S,!4/S"NA:"NA@;04T0_T
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M=/9>_R]7-JH7:SGI$+7S(O2C#6!_M(#4G^FL?B\9\AI68RFCF-]YCYPJH$,
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MVR G0)JER* .)X/XLL:$$E>9X'F:\%Z,C/T_I<B+3GMF@D]%?LAY+-ZS1^$
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M?C]IA0UY]Y+F82WD8_)L_P?_+V#=G?_\YV[3;-]V;S'6/T3 _I7PL?@W_+?
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MH($$#H:!0D,@<+RTS"PX7E !1*"8X36L9\#^+/M#>>Y%R9]EH@ 5"#'+ BK
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MI0\O-3,XY\*O%E2 3H8)/&]Y6:7%YL-@J\OWI<NS[T.54WA #&=.)2C7;S*
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MDO$M<+WM_U<Q]]^4/?L?4$L! A0#%     @ ,X)J5221-N!>!   ?!$  !$
M             ( !     &5V9V\M,C R,C$Q,3 N>'-D4$L! A0#%     @
M,X)J5<)Z&A[G!@  Q3X  !4              ( !C00  &5V9V\M,C R,C$Q
M,3!?9&5F+GAM;%!+ 0(4 Q0    ( #.":E4C6G10F (  %@.   5
M      "  :<+  !E=F=O+3(P,C(Q,3$P7VQA8BYX;6Q02P$"% ,4    "  S
M@FI5QHR7*Z@%  !K.0  %0              @ %R#@  979G;RTR,#(R,3$Q
M,%]P<F4N>&UL4$L! A0#%     @ ,X)J5:M"G.)9&P  1JX  !0
M     ( !310  &5V9V\M,C R,C$Q,3!X.&LN:'1M4$L! A0#%     @ ,X)J
M58H!8KB'KP  =E@% !<              ( !V"\  &5V9V\M,C R,C$Q,3!X
M97@Q9#$N:'1M4$L! A0#%     @ ,X)J54[JH !(#@  >TT  !<
M     ( !E-\  &5V9V\M,C R,C$Q,3!X97@U9#$N:'1M4$L%!@     '  <
*U $  !'N      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
